Some embodiments relate in part to endovascular prostheses and methods of deploying same. Embodiments may be directed more specifically to stent grafts and methods of making and deploying same within the body of a patient.
An aneurysm is a medical condition indicated generally by an expansion and weakening of the wall of an artery of a patient. Aneurysms can develop at various sites within a patient's body. Thoracic aortic aneurysms (TAAs) or abdominal aortic aneurysms (AAAs) are manifested by an expansion and weakening of the aorta which is a serious and life threatening condition for which intervention is generally indicated. Existing methods of treating aneurysms include invasive surgical procedures with graft replacement of the affected vessel or body lumen or reinforcement of the vessel with a graft.
Surgical procedures to treat aortic aneurysms can have relatively high morbidity and mortality rates due to the risk factors inherent to surgical repair of this disease as well as long hospital stays and painful recoveries. This is especially true for surgical repair of TAAs, which is generally regarded as involving higher risk and more difficulty when compared to surgical repair of AAAs. An example of a surgical procedure involving repair of a AAA is described in a book titled Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W. B. Saunders Company.
Due to the inherent risks and complexities of surgical repair of aortic aneurysms, endovascular repair has become a widely-used alternative therapy, most notably in treating AAAs. Early work in this field is exemplified by Lawrence, Jr. et al. in “Percutaneous Endovascular Graft: Experimental Evaluation”, Radiology (May 1987) and by Mirich et al. in “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study,” Radiology (March 1989). Commercially available endoprostheses for the endovascular treatment of AAAs include the AneuRx® stent graft manufactured by Medtronic, Inc. of Minneapolis, Minn., the Zenith® stent graft system sold by Cook, Inc. of Bloomington, Ind., the PowerLink® stent-graft system manufactured by Endologix, Inc. of Irvine, Calif., and the Excluder® stent graft system manufactured by W.L. Gore & Associates, Inc. of Newark, Del. A commercially available stent graft for the treatment of TAAs is the TAG™ system manufactured by W.L. Gore & Associates, Inc.
When deploying devices by catheter or other suitable instrument, it is advantageous to have a flexible and low profile stent graft and delivery system for passage through the various guiding catheters as well as the patient's sometimes tortuous anatomy. Many of the existing endovascular devices and methods for treatment of aneurysms, while representing significant advancement over previous devices and methods, use systems having relatively large transverse profiles, often up to 24 French. Also, such existing systems have greater than desired lateral stiffness, which can complicate the delivery process. In addition, the sizing of stent grafts may be important to achieve a favorable clinical result. In order to properly size a stent graft, the treating facility typically must maintain a large and expensive inventory of stent grafts in order to accommodate the varied sizes of patient vessels due to varied patient sizes and vessel morphologies. Alternatively, intervention may be delayed while awaiting custom size stent grafts to be manufactured and sent to the treating facility. As such, minimally invasive endovascular treatment of aneurysms is not available for many patients that would benefit from such a procedure and can be more difficult to carry out for those patients for whom the procedure is indicated.
What have been needed are stent graft systems and methods that are adaptable to a wide range of patient anatomies and that can be safely and reliably deployed using a flexible low profile system.
Some embodiments are directed to a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The stent may also include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. At least some of the enlarged longitudinal sections may be in axial alignment with each other. In some cases, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts. In some cases, the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. The enlarged longitudinal section may have an enlarged transverse dimension that is about 1.5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement for some embodiments.
Certain embodiments are directed to an endovascular stent graft, having a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The stent may also include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. All resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize at least one strut relative to the position of adjacent struts while the stent is in a constrained state in some embodiments. In some cases, at least some of the enlarged longitudinal sections may be in axial alignment with each other. In some instances, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts. In some instances, the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. The enlarged longitudinal section may have an enlarged transverse dimension that is about 1.5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement in some embodiments.
Some embodiments are directed to a method of loading a delivery catheter system with an endovascular stent graft. The endovascular stent graft may have a main body portion including at least one tubular portion made from at least one layer of flexible material, and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to separate and stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. In some cases, the self-expanding cylindrical stent of the stent graft may be constrained about a bushing of the delivery system such that the enlarged longitudinal section of the at least one resilient strut stabilizes the position of the at least one strut relative to the position of adjacent struts in the constrained state. In some instances, the stent may be releasably secured in the constrained stabilized state.
Some embodiments of an endovascular stent graft may include a main body portion having at least one tubular portion made from at least one layer of flexible material and a self-expanding anchor member. The self-expanding anchor member may include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion. In some cases, the endovascular stent graft may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and a distal end of the distal stent portion is secured to a proximal end of the main body portion. The endovascular stent graft may also be configured such that the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1.75 to about 2.0.
Some embodiments of a self-expanding anchor member include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion. In some cases, the anchor member may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1.75 to about 2.0.
Some embodiments of an endovascular stent graft may include a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may have a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. For such an embodiment, all of the resilient struts of the stent may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. In some cases at least some of the enlarged longitudinal sections may be in axial alignment with each other. In some instances, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts or the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. For some embodiments, the enlarged longitudinal section may have an enlarged transverse dimension that is about 1.5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement. In some cases, the enlarged longitudinal section includes an undulating configuration of the nominal strut or an oval enlargement of the nominal strut. In some instances, each strut of the stent may include an enlarged longitudinal section with only one enlarged longitudinal section or an enlarged longitudinal section with a plurality of enlarged longitudinal sections. For some embodiments, the struts having enlarged longitudinal sections may be disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent when the stent is in the constrained state. In some cases, the struts may be disposed in an undulating pattern. In some instances, the self-expanding cylindrical stent of the stent graft may include a superelastic alloy such as NiTi alloy.
Certain embodiments are described further in the following description, examples, claims and drawings.
FIGS. 6A and 6AA illustrate paired transverse cross section views of a strut embodiment of
FIGS. 6B and 6BB illustrate paired transverse cross section views of another strut embodiment of
FIGS. 6C and 6CC illustrate paired transverse cross section views of another strut embodiment of
FIGS. 6D and 6DD illustrate paired transverse cross section views of another strut embodiment of
FIGS. 6E and 6EE illustrate paired transverse cross section views of another strut embodiment of
The drawings illustrate embodiments of the invention and are not limiting. For clarity and ease of illustration, the drawings are not made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
Embodiments of the invention are directed generally to methods and devices for treatment of fluid flow vessels with the body of a patient. Treatment of blood vessels may be specifically indicated for some embodiments, and, more specifically, treatment of aneurysms, such as abdominal aortic aneurysms. Devices for such treatment modalities may include stents, grafts and stent graft assemblies that include at least one stent secured to a graft member.
For some embodiments, the modular graft assembly may be bifurcated for treatment of an abdominal aortic aneurysm. Such a graft assembly embodiment may include a bifurcated main body member, an ipsilateral graft extension and contralateral graft extension. The main body may have a wall portion that binds a main fluid flow lumen disposed therein. An ipsilateral leg of the main body may have an ipsilateral port and an ipsilateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the ipsilateral port. A contralateral leg of the main body may have a contralateral port and a contralateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the contralateral port. The main body, ipsilateral leg, and contralateral leg may form a bifurcated “Y” shaped configuration.
For some bifurcated embodiments, the main fluid flow lumen of the main body generally may have a larger transverse dimension and area than a transverse dimension and area of either of the fluid flow lumens of the ipsilateral leg or contralateral leg. A proximal anchor member may be disposed at a proximal end of the main body. The proximal anchor member may include a proximal self-expanding stent that is formed from an elongate element having a generally serpentine shape with four crowns or apices at either end. Each proximal apex or crown of the proximal stent may be coupled to alternating distal crowns or apices of an eight crown distal self-expanding stent. The distal self-expanding stent may be formed from an elongate element having a generally serpentine shape. A distal end of the distal stent may be mechanically coupled to a connector ring which may be embedded in graft material of the proximal end of the main body, or directly coupled to perforations in the proximal edge region of the main body. Embodiments of the connector ring may be generally circular in shape having regular undulations about the circumference that may be substantially sinusoidal in shape. The proximal stent may include outwardly extending barbs, that may be integrally formed with the struts of the stent for some embodiments, having sharp tissue penetrating tips that are configured to penetrate into tissue of an inside surface of a lumen within which the proximal stent is deployed in an expanded state. Although the proximal anchor member may include self-expanding stents, similar stents may be used that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either or both stents. The connector ring coupled to the proximal stent may also be inelastically expandable.
With regard to graft embodiments discussed herein, such as graft assembly, and components thereof, as well as graft extensions and, the term “proximal” refers to a location towards a patient's heart and the term “distal” refers to a location away from the patient's heart. With regard to delivery system catheters and components thereof discussed herein, the term “distal” refers to a location that is disposed away from an operator who is using the catheter and the term “proximal” refers to a location towards the operator.
A distal self-expanding stent member 170 may be disposed at the distal end 156 of the main body 152 and may be configured to engage an interior luminal surface 132 within the patient's vasculature 130. The distal self-expanding stent member 170 shown in
Embodiments of either the proximal connector ring 164 or distal connector ring 174 may be generally circular or cylindrical in shape with regular undulations about the circumference that may be substantially sinusoidal or zig-zag in shape. Some embodiments of either the proximal or distal self-expanding stent members 160, 170 may include outwardly extending barbs 165 (see
Although the proximal and distal self-expanding stent members 160 and 170 of the stent graft 150 has generally been described as including self-expanding stents, the proximal and distal self-expanding stent members 160 and 170 may also include similar stents that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either the proximal self-expanding stent member 160 or distal self-expanding stent member 170. Additionally, at least one of the proximal self-expanding stent member 160 and distal self-expanding stent member 170 may be made from or include a superelastic alloy, such as NiTi alloy.
The stent graft 150 may further include an optional inflation conduit (not shown) which may serve as a fill manifold for inflation of the inflatable portion 158 of the stent graft 150. The inflation conduit may include a distal end with an inflation port in fluid communication with an exterior portion of the main body 152 and extending from the distal end 156 into an interior volume of the inflatable portion 158 of the stent graft 150.
Some embodiments of the stent graft 150 may include radiopaque markers 116 that may be used to facilitate alignment of the stent graft 150. A radiopaque marker 116 configuration and imaging system may be used for alignment during positioning of the stent graft 150 in a patient.
Furthermore, any number of features may be incorporated into the stent graft 150 which may enable detection of all or part of the stent graft 150 under fluoroscopy or other suitable forms of imaging. For example, in general, the radiopaque markers 116, or other detection features, may be used to facilitate orthogonal orientation of the imaging axis or view. Once a substantially orthogonal view angle is achieved, an accurate axial position of the partially deployed stent graft 150 relative to the patient's vasculature may be achieved, avoiding parallax, ensuring precise placement of the stent graft 150 relative to significant branch vessels or other anatomic reference points. Parallax in some circumstances may cause error in axial placement of the stent graft 150 relative to the intended target site. Accurate positioning may be achieved with axial movement and adjustment of the stent graft 150 by manual manipulation of a proximal portion of the delivery catheter 100.
As shown in
Each of the releasable belts 104, 106, 108 and 110 may be configured to be independently released by retraction of one or more respective release wires 120. Release wires 120 may be disposed within an end loop or loops of the releasable belts 104, 106, 108 and 110 with the one or more release wires 120 holding the loops in fixed relation to each other. For this arrangement, retraction of one or more release wires 120 from the end loops releases the loops to allow them to move relative to each other which in turn removes the constraint of the belt members 104, 106, 108 and 110 about the respective proximal and distal self-expanding stent members 160 and 170. After at least partial deployment of the proximal stent member 160, finalizing the axial position of the stent graft 150 relative to the anatomy of the patient's vasculature 130 and treatment site may then be made. The axial positioning may be accomplished in some embodiments with the use of one or more radiopaque marker devices 116, as described above. Once the partially radially constrained stent graft 150 is axially aligned, the proximal self-expanding stent member 160 may then be fully deployed in order to engage and become secured to the luminal wall or interior luminal surface 132 of the patient's vasculature 130, as shown by way of example in
The proximal self-expanding stent member 160 may be disposed at and secured to a proximal end 154 of the main body 152. For example, the proximal self-expanding stent member 160 may have a first self-expanding stent member 200 secured to a second self-expanding stent member 202. Both the first and second self-expanding stent members 200 and 202 may have a somewhat tubular shape and may be secured together by one or more struts 168. Some embodiments of the struts 168 may have one or more cross sectional areas 169 that vary along the length of the strut 168. Such a configuration may be useful in avoiding points of concentrated stress in, for example, the proximal self-expanding stent member 160 or struts 168. The proximal self-expanding stent member 160 may include at least one barb 165 and/or enlarged portion 180 on each strut 168, every other strut 168 or combinations thereof. One proximal self-expanding stent member 160 embodiment may have a repeated strut 168 pattern having a more proximally placed barb 165 on one strut 168, an adjacent neighbor strut 168 with a more distally placed barb 165, and a following adjacent strut 168 with a centrally placed enlarged portion 180, as shown in
For some embodiments, the first self-expanding member 200 of the proximal self-expanding stent member 160 may further include a plurality of barbs 165 having sharp tissue engaging tips that are configured to extend radially outward and distally in a deployed expanded state. This configuration may be useful in order to engage tissue of an inner luminal surface 132 of a patient's vasculature 130 and mechanically anchor the stent graft 150 to the vasculature 130, in addition to the anchoring function provided by the outward radial force of the proximal self-expanding stent member 160 against the inner luminal surface 132 of the patient's vasculature 130 when the stent graft 150 is in a deployed state. The second self-expanding member 202 of the proximal self-expanding stent member 160 may be secured to the proximal end 154 of the main body 152 of the stent graft 150 with one or more struts 168 and/or connector members 216 mechanically coupled to a proximal connector ring 164.
When loaded on the delivery catheter 100, the first and second self-expanding members 200, 202 of the proximal self-expanding stent member 160 may be radially constrained by releasable belts 104 and 106 which may be releasably held in a constraining configuration by a release member, such as a release wire 120.
The strut 168 structure of the proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 may be formed from a cylindrical metal tube structure which is carved or bore by laser or other cutting device. Thereafter, the cut tube may be heat set into two separate forms or states such as an expanded state and non-expanded/contracted state.
The staged deployment of the proximal self-expanding stent member 160 may also facilitate self-alignment of the stent graft 150. For instance, upon deployment of the proximal self-expanding stent member 160, the graft may be free to expand and enable distal fluid flow to flow through the stent graft 150 and create a “windsock” effect. That is, the distal fluid flow may apply a slight distal force generally upon the main body 152. This distal force may help to align at least the main body 152 and proximal self-expanding stent member 160 within the patient's vasculature 130, which may be particularly advantageous during deployment of the stent graft 150 within the angulated vasculature 130, for example.
In some embodiments of the stent graft 150, one or more struts 168 may include tuck pads 166. Additionally, the one or more struts 168 may have tuck pads 166 positioned such that the tuck pads 166 are generally aligned with a barb 165 extending from an adjacent strut 168, as shown in
As illustrated in
In some embodiments, one or more struts 168 may have a tapered section 300. For example, one or more struts 168 may have a tapered section 300 in order to evenly distribute strain induced at least when the stent is in a constrained state. The strut 168 may taper from a first end portion of the strut 168 to a smaller transverse cross section towards a middle portion of the strut 168. As shown in
Optional taper (or tapers) may be incorporated into one or more of the struts 168 of the various stent 500 embodiments, as well as the various connector members 216. In general, incorporating one or more tapers into one or more of the struts 168 in one or more stents 500 may provide greater space in the tapered section 300 to accommodate alternative features such as barbs 165 and tuck pads 166. In addition, it may allow for a smaller deployment profile when the components are in a radially collapsed delivery configuration. When configuring the various stents 500 into this reduced diameter delivery profile (non-expanded/constrained state), the stents 500 may experience a large degree of bending strain that may be poorly distributed. Tapering certain stent 500 struts 168 in particular locations may help to distribute this strain more evenly throughout the stent 500 and/or strut 168 which may assist in preventing strain damage to the stent 500.
FIGS. 6A-6EE, illustrate a variety of examples of varying transverse cross-sectional views taken at two different locations along a single strut 168. These figures illustrate examples of the different shapes and sizes a single cross sectional area 169 of a strut 168 may have. For instance, as described above, FIGS. 6A and 6AA show a pair of transverse cross section views of the strut 168 embodiment of
A proximal self-expanding stent member 160 may have, for example, one or more struts 168 having a proximal end 400 portion and/or distal end 404 portion which may be made from NiTi and an effective maximum strut 168 width ranging from about 0.016 to about 0.032 inch; particularly from about 0.022 inch and about 0.028 inch, and a minimum strut 168 width between about 0.010 inch and about 0.026 inch; particularly from about 0.012 inch and about 0.022 inch. Additional tapered strut 168 embodiments are described and shown herein in the figures which may be used in other anchor members (such as the proximal and distal self-expanding stent members 160 and 170), stent 500 embodiments or connector members 216 described herein, and may be incorporated in any number of components and made from any number of materials. For example, tapering of the struts 168 in any configuration described herein may improve the strain distribution at least between the proximal end 400 portions and distal end 404 portions of the struts 168.
Various types of taper features or configurations may be implemented in any number of struts 168 for achieving a variety of strut 168 characteristics. For example, one or more struts 168 may include a taper having an offset radii and/or combinations of elliptical and/or circular apex radii in order to further cause the desired behavior during assembly into a reduced-diameter delivery configuration as well as effective delivery and performance in vivo. For example, the proximal end 400 portion, or apex, width may be the minimum width of the strut 168 which untapers towards the middle portion 402 of the strut 168, which may have the maximum width of the strut 168. The tapering from the proximal end 400 portion to the middle portion 402 of the strut 168 may be continuous, stepped in discrete steps 410 with straight untapered portions between each discrete step (as shown by way of example in
The strut 168 may include an enlarged portion 180 located in about the middle portion 402 of one or more of the struts 168, as shown by way of example in
In some cases, the one or more enlarged longitudinal sections or enlarged portions 180 may have an enlarged transverse dimension that is about 1.5 times to about 3 times the nominal transverse dimension of the strut 168 in a direction of the enlargement. Additionally, the enlarged portions 180 may have an undulating configuration of the nominal strut 168. Furthermore, the enlarged portion 180 may have an oval enlargement of the nominal strut. Each strut 168 of the stent 500 having an enlarged portion 168 along the length of the strut 168 may have only one enlarged portion 180. Alternatively, each strut 168 of the stent 500 having an enlarged portion 180 along the length of the strut 168 may have more than one enlarged portion 180. The enlarged portions 180 are not limited to what are described and shown herein, and may be sized, featured, shaped, and proportioned in any number of ways that may assist in assembly or use of the stent 500. Additionally, any number of materials may be used and may vary between struts 168, anchor members (such as the proximal and distal self-expanding strut members 160 and 170), and/or stents 500.
One or more struts 168 of a stent embodiment 500 may have a stepped taper 302 feature generally along the length of the strut 168. For example, one or more struts 168 may have a stepped taper 302 from the proximal end 400 to the respective middle portion 402 of the strut 168 and/or a stepped taper 302 from the distal end 404 to the middle portion 402 of the strut 168, wherein the stepped taper 302 may be in either radial direction about the longitudinal axis of the strut 168, as shown by way of example in
In addition, stent embodiments 500 may include struts 168 including tuck pads 166, which may be positioned along a strut 168 such that the tuck pads 166 are axially aligned with a barb 165 positioned on a neighboring strut 168. Similar to the barbs 165 and enlarged portions 180, the number, dimensions, configurations and orientations of the tuck pads 166 may vary between struts 168, stent embodiments 500 and anchor members (such as the proximal and distal self-expanding stent members 160 and 170 described herein).
During preparation of a stent graft embodiment 150 (and therefore one or more proximal self-expanding stent members 160) into a reduced diameter delivery configuration, one or more barbs 165 may be placed behind a corresponding strut 168 and/or tuck pad 166, if present, in order to prevent the barbs 165 from contacting the inside of a outer sheath 102 or delivery catheter 100 during delivery of the stent graft 150 and from undesired contact with the interior luminal surface 132 of the patient's vasculature 130. As described in U.S. patent application Ser. No. 09/917,371 to Chobotov et al., now U.S. Pat. No. 6,761,733, and which is incorporated by reference herein in its entirety, a release belt may be disposed in one or more grooves (not shown) disposed on one or more struts 168 which may assist in retaining the proximal self-expanding stent member 160 in the reduced diameter delivery configuration.
For example, upon deployment of stent graft 150, and more particularly the proximal self-expanding stent member 160, (typically accomplished, at least in part, by release of one or more belts, such as the proximal releasable belts 104 and 106), the radial expansion of the proximal self-expanding stent member 160 results in a displacement of struts 168 so that the distance between them increases. Eventually, the displacement between the struts 168 become large enough to enable the barbs 165 to be released from behind the adjacent strut 168 and/or tuck pad 166 and engage the interior luminal surface 132 of the patient's vasculature 130. In general, the barbs 165 may release into a position suitable for engaging the interior luminal surface 132 of a patient's vasculature with a time constant that is generally an order of magnitude lower than the time constant associated with the radial expansion of the stent 500 embodiment or anchor member (such as the proximal self-expanding stent member 160). In other words, during the stent 500 or anchor member deployment process, the one or more barbs 165 may complete their deployment before the stent 500 or anchor member is fully expanded so that the barbs 165 may engage the interior luminal surface 132 of the vasculature 130 with maximum effectiveness.
Referring again to
As discussed above, some embodiments of a modular endovascular stent graft assembly may include a bifurcated graft member 600 with a proximal stent or anchor member 602 secured thereto. In some cases, the main body member 604 may be formed from a supple graft material, such as ePTFE, having a main fluid flow lumen 606 therein.
The inflatable channels of the network of inflatable channels 616 may be disposed on any portion of the main graft or main body member 604 including the ipsilateral and contralateral legs 608 and 612. The network of inflatable channels 616 may be configured to accept a hardenable fill material to provide structural rigidity to the main body 604 member when the network of inflatable channels 616 are in an inflated state and the inflation material has been cured or hardened. Radiopaque inflation material may be used to facilitate monitoring of the fill process and subsequent engagement of graft extensions. The network of inflatable channels 616 may also include at least one inflatable cuff 624 disposed on a proximal portion of the main body member which may be configured to seal against an inside surface of a patient's vessel, such as the aorta.
The proximal anchor member 626, which may have a substantially tubular or cylindrical configuration, may be disposed at a proximal end 628 of the main body member 604 and secured to the main body member 604 in any suitable manner including stitching, adhesive bonding, welding, and the like. The proximal anchor member 626 may also be secured to the main body 604 with a resilient connector ring (not shown) which may be embedded in a proximal end or portion 628 the main body 604. The proximal anchor member 626 may have a self-expanding proximal stent portion 630 secured to a self-expanding distal stent portion 632. Each of these stent portions 630 and 632 may include an undulating elongate stent element that may be disposed in a somewhat serpentine or sinusoidal configuration, as shown above with regard to stent members 160 and 170. Each of the stent portions 630 and 632 of the proximal anchor member 626 of the stent graft 600 in
In some cases, the proximal stent portion 630 may be secured to the distal stent portion 632 with one or more struts or strut segments 638 disposed between the respective proximal and distal stent sections 630 and 632. Some embodiments of such interconnecting struts 638 may have a cross sectional area that is substantially the same as or greater than a cross sectional area of proximal stent portions 630 or distal stent portions 632 adjacent the strut 638. Such configurations may be useful in avoiding points of concentrated stress in the proximal anchor member 602 or struts 638 which couple components thereof. For some embodiments, the proximal stent portion 630 of the proximal anchor member 602 may further include a plurality of barbs 640 having sharp tissue engaging tips 642 that are configured to extend in a radial outward direction in a deployed expanded state (see
At least one tubular ipsilateral graft extension 644 having a fluid flow lumen 646 disposed therein may be deployed with the fluid flow lumen 646 of the graft extension 644 sealed to and in fluid communication with the fluid flow lumen 610 of the ipsilateral leg 608 of the main body member 604. In addition, at least one tubular contralateral graft extension 648 having a fluid flow lumen 650 disposed therein may be deployed with the fluid flow lumen 650 of the graft extension 648 sealed to and in fluid communication with the fluid flow lumen 614 of the contralateral leg 612 of the main body member 604. For some embodiments, the graft extensions 644 and 648 may include an interposed self-expanding stent 652 disposed between at least one outer layer and at least one inner layer of supple layers of graft material. The interposed stent disposed between the outer layer and inner layer of graft material may be formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. For some embodiments, the interposed stent 652 may include a superelastic alloy such as superelastic NiTi alloy. In addition, the graft material of each graft extension 644 and 648 may further include at least one axial zone of low permeability for some embodiments.
For some embodiments, an outside surface of the graft extension 648 may be sealed to an inside surface of the contralateral leg 612 of the main body 604 when the graft extension 648 is in a deployed state. For some embodiments, the axial length of the ipsilateral and contralateral legs 608 and 612 may be sufficient to provide adequate surface area contact with outer surfaces of graft extensions 644 and 648 to provide sufficient friction to hold the graft extensions 644 and 648 in place. For some embodiments, the ipsilateral and contralateral legs 608 and 612 may have an axial length of at least about 2 cm. For some embodiments, the ipsilateral and contralateral legs 608 and 612 may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
For the bifurcated stent graft embodiment 600 discussed above or any other suitable stent graft embodiment discussed herein that includes a proximal self-expanding anchor member 602, it may be desirable in some cases to constrain each of the proximal and distal stent portions 630 and 632 separately so that each of the proximal and distal stent portions 630 and 632 of the proximal anchor member 602 can be deployed from a radially constrained state independent of each other.
The stent graft 600 of
In such cases, a proximal anchor member 602 configured to allow the distal end 656 of the distal stent portion 632 to so expand may be desirable. For example, the markers 654 disposed at the distal end 656 of the distal stent portion 632 are substantially open and are close to or in contact with the inner wall 662 of the patient's aorta 68 providing good visualization of the position of the partially deployed stent graft 600 under fluoroscopy. This configuration may allow the physician deploying the stent graft 600 to visualize the position of the stent graft 600 and accurately predict what the final position of the stent graft 600 will be after complete deployment. However, such a configuration may also allow the physician to adjust the position of the stent graft 600 prior to full deployment of the proximal anchor member 602. In other words, the stent graft 600 and markers 654 at the distal end 656 of the distal stent portion 632 are sufficiently expanded so that the physician can easily see how the stent graft 600 will be positioned when fully deployed before the physician has deployed the proximal stent portion 630 in which case the barbs 640 or other tissue engaging members of the proximal stent portion 630 engage the tissue of the inner wall 662 of the patient's aorta 618.
We have found that in some instances, in order to configure an anchor member 602 such that the distal end 656 of the distal stent portion 632 opens or radially expands sufficiently upon release from a constrained state, that certain design parameters or criteria may be desirable. In particular, such a stent portion 632 may benefit from a configuration that produces a good distal opening force or maximum opening force in an outward radial direction. In order to produce a generous opening force in an outward radial direction, the section of the struts 634 and crowns 636 of the proximal and distal stent portions 630 and 632 may be increased, however, it may also be desirable to adjust the tapering profile of the struts 634 in order to maintain a substantially even distribution of strain throughout the structure of the stent portions 630 and 632. For some embodiments, a useful outward opening force may include about 0.5 to about 0.75 lbf of force for a stent embodiment that is about 14 mm to about 16 mm in outer diameter in a relaxed unconstrained state.
In cases such as the stent graft embodiment 600 of
It has also been discovered that for such proximal anchor member embodiments 600 as shown in
Another design parameter that may be useful when maximizing opening force and minimizing peak strain within a proximal anchor member 602 is selection of the inner crown radius of the crowns 636 at each end of the respective proximal and distal stent portions 630 and 632.
For some particular stent graft embodiments 600 having a bifurcated main body 604 and a multi-element proximal anchor member 602, the proximal anchor member 602 may be configured to open to a maximum diameter of about 29 mm to about 31 mm, more specifically, about 30 mm, the proximal anchor member may have an overall axial length Lstent of about 35 mm to about 37 mm, more specifically, about 36 mm, an opening force of about 0.5 lbf to about 0.7 lbf, more specifically, about 0.6 lbf, and a ratio of the axial length 680 of the anchor member 602 Lstent divided by the axial length 678 of the proximal stent portion 630 Lproximal of about 2.0 to about 2.2, more specifically, about 2.1. Such an embodiment 600 may also have a distal stent portion 632 with a strut taper configuration wherein the length 680 of the proximal anchor member 602 as a whole Lstent divided by the length 682 of the tapered strut 639 from the crown 686 of the distal stent portion 632 at a proximal end thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632 (Ltaper) is about 3.0 to about 3.2, more specifically, about 3.1. Many other embodiments following the design parameters discussed above may also be used in order to maximize opening force and minimize peak strain within the proximal anchor member 602. As discussed above, these design parameters may also be used singly or in any combination in order to achieve the desired results in either single element stents 160 and 170 or multi-element stents 600 having a proximal stent portion 630, distal stent portion 632 or any other number of stent portions.
While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.
The number of barbs, enlarged portions or tapers per strut, the length of each barb, enlarged portions or tapers, each of the barb angles or tapered angle described above, and the barb, enlarged portion or tapered orientation may vary from barb to barb, enlarged portion to enlarged portion, strut to strut within a single stent or between multiple stents within a single graft.
The entirety of each patent, patent application, publication and document referenced herein hereby is incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these publications or documents.
Modifications may be made to the foregoing without departing from the basic aspects of the invention. Although embodiments of the invention have been described in substantial detail with reference to one or more specific embodiments, those of ordinary skill in the art will recognize that changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the invention.
Embodiments illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein. Thus, for example, in each instance herein any of the terms “comprising,” “consisting essentially of,” and “consisting of” may be replaced with either of the other two terms. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the invention claimed. The term “a” or “an” can refer to one of or a plurality of the elements it modifies (e.g., “a reagent” can mean one or more reagents) unless it is contextually clear either one of the elements or more than one of the elements is described. Thus, it should be understood that although embodiments have been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and such modifications and variations are considered within the scope of this invention.
Certain embodiments of the invention are set forth in the claim(s) that follow(s).
This application claims priority under 35 U.S.C. 119(e) from U.S. Provisional Patent Application No. 61/620,362, filed Apr. 4, 2012, by D. Parsons et al., titled Durable Stent Graft with Tapered Struts and Stable Delivery Methods and Devices, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3076737 | Roberts | Feb 1963 | A |
3540431 | Uddin | Nov 1970 | A |
3631854 | Fryer et al. | Jan 1972 | A |
3657744 | Ersek | Apr 1972 | A |
3669586 | Kramer | Jun 1972 | A |
3814137 | Martinez | Jun 1974 | A |
3818511 | Goldberg et al. | Jun 1974 | A |
3902198 | Rathjen | Sep 1975 | A |
3991767 | Miller et al. | Nov 1976 | A |
4096227 | Gore | Jun 1978 | A |
4110392 | Yamasaki | Aug 1978 | A |
4140126 | Choudhury | Feb 1979 | A |
4183102 | Guiset | Jan 1980 | A |
4187390 | Gore | Feb 1980 | A |
4208745 | Okita | Jun 1980 | A |
4214587 | Sakura, Jr. | Jul 1980 | A |
4229838 | Mano | Oct 1980 | A |
4248924 | Okita | Feb 1981 | A |
4330126 | Rumble | May 1982 | A |
4385093 | Hubis | May 1983 | A |
4416028 | Eriksson et al. | Nov 1983 | A |
4434797 | Silander | Mar 1984 | A |
4459252 | MacGregor | Jul 1984 | A |
4474630 | Planck et al. | Oct 1984 | A |
4478665 | Hubis | Oct 1984 | A |
4482516 | Bowman et al. | Nov 1984 | A |
4497074 | Rey et al. | Feb 1985 | A |
4503569 | Dotter | Mar 1985 | A |
4512338 | Balko et al. | Apr 1985 | A |
4550447 | Seiler, Jr. et al. | Nov 1985 | A |
4552707 | How | Nov 1985 | A |
4562596 | Kornberg | Jan 1986 | A |
4577631 | Kreamer | Mar 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4592754 | Gupte et al. | Jun 1986 | A |
4617932 | Kornberg | Oct 1986 | A |
4647416 | Seiler, Jr. et al. | Mar 1987 | A |
4655769 | Zachariades | Apr 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4665906 | Jervis | May 1987 | A |
4705517 | DiPisa, Jr. | Nov 1987 | A |
4731073 | Robinson | Mar 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4739762 | Palmaz | Apr 1988 | A |
4740207 | Kreamer | Apr 1988 | A |
4743480 | Campbell et al. | May 1988 | A |
4760102 | Moriyama et al. | Jul 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4816028 | Kapadia et al. | Mar 1989 | A |
4830003 | Wolff et al. | May 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4871365 | Dumican | Oct 1989 | A |
4877661 | House et al. | Oct 1989 | A |
4902423 | Bacino | Feb 1990 | A |
4932938 | Goldberg et al. | Jun 1990 | A |
4941870 | Okada et al. | Jul 1990 | A |
4955899 | Della et al. | Sep 1990 | A |
4957669 | Primm | Sep 1990 | A |
4985296 | Mortimer, Jr. | Jan 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5019090 | Pinchuk | May 1991 | A |
5041126 | Gianturco | Aug 1991 | A |
5052998 | Zimmon | Oct 1991 | A |
5059211 | Stack et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5098625 | Huang et al. | Mar 1992 | A |
5100422 | Berguer et al. | Mar 1992 | A |
5104399 | Lazarus | Apr 1992 | A |
5104400 | Berguer et al. | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5108424 | Hoffman, Jr. et al. | Apr 1992 | A |
5110527 | Harada et al. | May 1992 | A |
5116365 | Hillstead | May 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5123917 | Lee | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5135536 | Hillstead | Aug 1992 | A |
5139480 | Hickle et al. | Aug 1992 | A |
5150304 | Berchem et al. | Sep 1992 | A |
5151105 | Kwan-Gett | Sep 1992 | A |
5152782 | Kowligi et al. | Oct 1992 | A |
5156620 | Pigott | Oct 1992 | A |
5158548 | Lau et al. | Oct 1992 | A |
5163955 | Love | Nov 1992 | A |
5167614 | Tessmann | Dec 1992 | A |
5171262 | MacGregor | Dec 1992 | A |
5192310 | Herweck et al. | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5197978 | Hess | Mar 1993 | A |
5201757 | Heyn et al. | Apr 1993 | A |
5202352 | Okada et al. | Apr 1993 | A |
5207695 | Trout, III | May 1993 | A |
5217483 | Tower | Jun 1993 | A |
5219355 | Parodi et al. | Jun 1993 | A |
5226913 | Pinchuk | Jul 1993 | A |
5234456 | Silvestini | Aug 1993 | A |
5250059 | Andreas et al. | Oct 1993 | A |
5275622 | Lazarus et al. | Jan 1994 | A |
5282823 | Schwartz et al. | Feb 1994 | A |
5282824 | Gianturco | Feb 1994 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5290305 | Inoue | Mar 1994 | A |
5292331 | Boneau | Mar 1994 | A |
5304200 | Spaulding | Apr 1994 | A |
5314472 | Fontaine | May 1994 | A |
5316023 | Palmaz et al. | May 1994 | A |
5320100 | Herweck et al. | Jun 1994 | A |
5321109 | Bosse et al. | Jun 1994 | A |
5330528 | Lazim | Jul 1994 | A |
5334164 | Guy et al. | Aug 1994 | A |
5334201 | Cowan | Aug 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5344444 | Glastra | Sep 1994 | A |
5344451 | Dayton | Sep 1994 | A |
5350398 | Pavcnik | Sep 1994 | A |
5354310 | Garnic et al. | Oct 1994 | A |
5354329 | Whalen | Oct 1994 | A |
5360443 | Barone et al. | Nov 1994 | A |
5365996 | Crook | Nov 1994 | A |
5366504 | Andersen et al. | Nov 1994 | A |
5370682 | Schmitt | Dec 1994 | A |
5370691 | Samson | Dec 1994 | A |
5374473 | Knox et al. | Dec 1994 | A |
5382261 | Palmaz | Jan 1995 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5383928 | Scott et al. | Jan 1995 | A |
5387235 | Chuter et al. | Feb 1995 | A |
5389106 | Tower et al. | Feb 1995 | A |
5391147 | Imran et al. | Feb 1995 | A |
5397345 | Lazarus | Mar 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5405378 | Strecker | Apr 1995 | A |
5405379 | Lane | Apr 1995 | A |
5411550 | Herweck et al. | May 1995 | A |
5415634 | Glynn et al. | May 1995 | A |
5423851 | Samuels | Jun 1995 | A |
5433909 | Martakos et al. | Jul 1995 | A |
5437900 | Kuzowski | Aug 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5443458 | Eury | Aug 1995 | A |
5443498 | Fountaine | Aug 1995 | A |
5445646 | Euteneuer et al. | Aug 1995 | A |
5447152 | Kohsai et al. | Sep 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5456713 | Chuter | Oct 1995 | A |
5464419 | Glastra | Nov 1995 | A |
5464449 | Ryan et al. | Nov 1995 | A |
5466509 | Kowllgl et al. | Nov 1995 | A |
5474824 | Martakos et al. | Dec 1995 | A |
5476506 | Lunn | Dec 1995 | A |
5476589 | Bacino | Dec 1995 | A |
5478330 | Imran et al. | Dec 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5505887 | Zdrahala et al. | Apr 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5507770 | Turk | Apr 1996 | A |
5512360 | King | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5522880 | Barone et al. | Jun 1996 | A |
5522881 | Lentz | Jun 1996 | A |
5522883 | Slater et al. | Jun 1996 | A |
5524633 | Heaven et al. | Jun 1996 | A |
5527353 | Schmitt | Jun 1996 | A |
5527355 | Ahn | Jun 1996 | A |
5529653 | Glastra | Jun 1996 | A |
5529820 | Nomi et al. | Jun 1996 | A |
5534024 | Rogers et al. | Jul 1996 | A |
5536274 | Neuss | Jul 1996 | A |
5545135 | Iacob et al. | Aug 1996 | A |
5549662 | Fordenbacher | Aug 1996 | A |
5549663 | Cottone, Jr. | Aug 1996 | A |
5552100 | Shannon et al. | Sep 1996 | A |
5554180 | Turk | Sep 1996 | A |
5554181 | Das | Sep 1996 | A |
5554183 | Nazari | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5556414 | Turi | Sep 1996 | A |
5556426 | Popadiuk et al. | Sep 1996 | A |
5560986 | Mortimer, Jr. | Oct 1996 | A |
5562697 | Christiansen | Oct 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5562726 | Chuter | Oct 1996 | A |
5562727 | Turk et al. | Oct 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5569295 | Lam | Oct 1996 | A |
5571171 | Barone et al. | Nov 1996 | A |
5571172 | Chin | Nov 1996 | A |
5571173 | Parodi | Nov 1996 | A |
5575817 | Martin | Nov 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5578071 | Parodi | Nov 1996 | A |
5578072 | Barone et al. | Nov 1996 | A |
5588964 | Imran et al. | Dec 1996 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5591197 | Orth et al. | Jan 1997 | A |
5591229 | Parodi | Jan 1997 | A |
5597378 | Jervis | Jan 1997 | A |
5603721 | Lau et al. | Feb 1997 | A |
5607478 | Lentz et al. | Mar 1997 | A |
5609624 | Kalis | Mar 1997 | A |
5609625 | Piplani et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5609628 | Keranen | Mar 1997 | A |
5609629 | Fearnot | Mar 1997 | A |
5612885 | Love | Mar 1997 | A |
5618301 | Hauenstein et al. | Apr 1997 | A |
5620763 | House et al. | Apr 1997 | A |
5626599 | Bourne et al. | May 1997 | A |
5628783 | Quiachon et al. | May 1997 | A |
5628786 | Banas et al. | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5632840 | Campbell | May 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5641373 | Shannon et al. | Jun 1997 | A |
5645915 | Kranzler et al. | Jul 1997 | A |
5649978 | Samson | Jul 1997 | A |
5653745 | Trescony et al. | Aug 1997 | A |
5653746 | Schmitt | Aug 1997 | A |
5656029 | Imran et al. | Aug 1997 | A |
5662675 | Stockert et al. | Sep 1997 | A |
5662700 | Lazarus | Sep 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5665117 | Rhodes | Sep 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5669936 | Lazarus | Sep 1997 | A |
5676671 | Inoue | Oct 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5681346 | Orth et al. | Oct 1997 | A |
5683449 | Marcade | Nov 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5683453 | Palmaz | Nov 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5693083 | Baker et al. | Dec 1997 | A |
5693084 | Chuter | Dec 1997 | A |
5693087 | Parodi | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5697968 | Rogers et al. | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5700285 | Myers et al. | Dec 1997 | A |
5707378 | Ahn et al. | Jan 1998 | A |
5707388 | Lauterjung | Jan 1998 | A |
5708044 | Branca | Jan 1998 | A |
5709701 | Parodi | Jan 1998 | A |
5709703 | Lukie et al. | Jan 1998 | A |
5712315 | Dolan | Jan 1998 | A |
5713917 | Leonhardt et al. | Feb 1998 | A |
5716393 | Lindenberg et al. | Feb 1998 | A |
5716395 | Myers et al. | Feb 1998 | A |
5718159 | Thompson | Feb 1998 | A |
5718973 | Lewis et al. | Feb 1998 | A |
5720776 | Chuter et al. | Feb 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5725547 | Chuter | Mar 1998 | A |
5725549 | Lam | Mar 1998 | A |
5728131 | Frantzen et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5735892 | Myers et al. | Apr 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5735897 | Buirge | Apr 1998 | A |
5741324 | Glastra | Apr 1998 | A |
5741325 | Chaikof et al. | Apr 1998 | A |
5747128 | Campbell et al. | May 1998 | A |
5749880 | Banas et al. | May 1998 | A |
5749894 | Engleson | May 1998 | A |
5749920 | Quiachon et al. | May 1998 | A |
5749921 | Lenker et al. | May 1998 | A |
5755772 | Evans et al. | May 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5766203 | Imran et al. | Jun 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5769885 | Quiachon et al. | Jun 1998 | A |
5769887 | Brown et al. | Jun 1998 | A |
5772884 | Tanaka et al. | Jun 1998 | A |
5776142 | Gunderson | Jul 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776183 | Kanesaka et al. | Jul 1998 | A |
5780807 | Saunders | Jul 1998 | A |
5782789 | Herweck et al. | Jul 1998 | A |
5782838 | Beyar et al. | Jul 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5782909 | Quiachon et al. | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5788626 | Thompson | Aug 1998 | A |
5789047 | Sasaki et al. | Aug 1998 | A |
5797951 | Mueller | Aug 1998 | A |
5798924 | Eufinger et al. | Aug 1998 | A |
5799384 | Schwartz et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5800512 | Lentz et al. | Sep 1998 | A |
5800515 | Nadal et al. | Sep 1998 | A |
5800518 | Piplani et al. | Sep 1998 | A |
5800522 | Campbell et al. | Sep 1998 | A |
5800524 | Borghi | Sep 1998 | A |
5800526 | Anderson et al. | Sep 1998 | A |
5810870 | Myers et al. | Sep 1998 | A |
5810872 | Kanesaka et al. | Sep 1998 | A |
5814405 | Branca et al. | Sep 1998 | A |
5817102 | Johnson et al. | Oct 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824039 | Piplani et al. | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5824044 | Quiachon et al. | Oct 1998 | A |
5824046 | Smith et al. | Oct 1998 | A |
5824058 | Ravenscroft et al. | Oct 1998 | A |
5827289 | Reiley et al. | Oct 1998 | A |
5827310 | Marin et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5833651 | Donovan et al. | Nov 1998 | A |
5833707 | Mcintyre et al. | Nov 1998 | A |
5836964 | Richter et al. | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5840775 | Howard, Jr. et al. | Nov 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5843160 | Rhodes | Dec 1998 | A |
5843162 | Inoue | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5843166 | Lentz et al. | Dec 1998 | A |
5843167 | Dwyer et al. | Dec 1998 | A |
5843170 | Ahn | Dec 1998 | A |
5843173 | Shannon et al. | Dec 1998 | A |
5843175 | Frantzen | Dec 1998 | A |
5853419 | Imran | Dec 1998 | A |
5855598 | Pinchuk | Jan 1999 | A |
5858556 | Eckert et al. | Jan 1999 | A |
5861027 | Trapp | Jan 1999 | A |
5871536 | Lazarus | Feb 1999 | A |
5871537 | Holman et al. | Feb 1999 | A |
5871538 | Dereume | Feb 1999 | A |
5873906 | Lau et al. | Feb 1999 | A |
5876432 | Lau et al. | Mar 1999 | A |
5891193 | Robinson et al. | Apr 1999 | A |
5904713 | Leschinsky | May 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5906641 | Thompson et al. | May 1999 | A |
5910168 | Meyers et al. | Jun 1999 | A |
5910277 | Ishino et al. | Jun 1999 | A |
5911754 | Kanesaka et al. | Jun 1999 | A |
5916264 | Von Oepen et al. | Jun 1999 | A |
5919204 | Lukic et al. | Jul 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5925061 | Ogi et al. | Jul 1999 | A |
5925075 | Myers et al. | Jul 1999 | A |
5931865 | Silverman et al. | Aug 1999 | A |
5935667 | Calcote et al. | Aug 1999 | A |
5939198 | Howard, Jr. et al. | Aug 1999 | A |
5944750 | Tanner et al. | Aug 1999 | A |
5948016 | Jang | Sep 1999 | A |
5954729 | Bachmann et al. | Sep 1999 | A |
5955016 | Goldfarb | Sep 1999 | A |
5957973 | Quiachon et al. | Sep 1999 | A |
5961545 | Lentz et al. | Oct 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5968090 | Ratcliff et al. | Oct 1999 | A |
5972023 | Tanner et al. | Oct 1999 | A |
5972027 | Johnson | Oct 1999 | A |
5972441 | Campbell et al. | Oct 1999 | A |
5976155 | Foreman et al. | Nov 1999 | A |
5976179 | Inoue | Nov 1999 | A |
5976192 | McIntyre et al. | Nov 1999 | A |
5976650 | Campbell et al. | Nov 1999 | A |
5980530 | Willard et al. | Nov 1999 | A |
5980570 | Simpson | Nov 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
5984956 | Tweden et al. | Nov 1999 | A |
5984964 | Roberts et al. | Nov 1999 | A |
5989287 | Yang et al. | Nov 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
5993489 | Lewis et al. | Nov 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
6001123 | Lau | Dec 1999 | A |
6004346 | Wolff et al. | Dec 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6004348 | Banas et al. | Dec 1999 | A |
6007575 | Samuels | Dec 1999 | A |
6015429 | Lau et al. | Jan 2000 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6015432 | Rakos et al. | Jan 2000 | A |
6017362 | Lau | Jan 2000 | A |
6017364 | Lazarus | Jan 2000 | A |
6019778 | Wilson et al. | Feb 2000 | A |
6019779 | Thorud et al. | Feb 2000 | A |
6019787 | Richard et al. | Feb 2000 | A |
6022359 | Frantzen | Feb 2000 | A |
6024763 | Lenker et al. | Feb 2000 | A |
6025044 | Campbell et al. | Feb 2000 | A |
6027779 | Campbell et al. | Feb 2000 | A |
6027811 | Campbell et al. | Feb 2000 | A |
6030413 | Lazarus | Feb 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6030415 | Chuter | Feb 2000 | A |
6036640 | Corace et al. | Mar 2000 | A |
6036702 | Bachinski et al. | Mar 2000 | A |
6036723 | Anidjar et al. | Mar 2000 | A |
6036724 | Lentz et al. | Mar 2000 | A |
6036725 | Avellanet | Mar 2000 | A |
6039754 | Caro | Mar 2000 | A |
6039758 | Quiachon et al. | Mar 2000 | A |
6042589 | Marianne | Mar 2000 | A |
6042605 | Martin et al. | Mar 2000 | A |
6042606 | Frantzen | Mar 2000 | A |
6045557 | White et al. | Apr 2000 | A |
6048484 | House et al. | Apr 2000 | A |
6051020 | Goicoechea et al. | Apr 2000 | A |
6053943 | Edwin et al. | Apr 2000 | A |
6059821 | Anidjar et al. | May 2000 | A |
6059823 | Holman et al. | May 2000 | A |
6060534 | Ronan et al. | May 2000 | A |
6063114 | Nash et al. | May 2000 | A |
6068626 | Harrington et al. | May 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6075180 | Sharber et al. | Jun 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6077298 | Tu et al. | Jun 2000 | A |
6090128 | Douglas | Jul 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6096052 | Callister et al. | Aug 2000 | A |
6096070 | Ragheb et al. | Aug 2000 | A |
6098630 | Papazoglou | Aug 2000 | A |
6102918 | Kerr | Aug 2000 | A |
6102938 | Evans et al. | Aug 2000 | A |
6102940 | Robichon et al. | Aug 2000 | A |
6103172 | Newman et al. | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6110198 | Fogarty et al. | Aug 2000 | A |
6113628 | Borghi | Sep 2000 | A |
6117168 | Yang et al. | Sep 2000 | A |
6123722 | Fogarty et al. | Sep 2000 | A |
6124523 | Banas et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129756 | Kugler et al. | Oct 2000 | A |
6132457 | Chobotov | Oct 2000 | A |
6132459 | Piplani et al. | Oct 2000 | A |
6139572 | Campbell et al. | Oct 2000 | A |
6142973 | Carleton et al. | Nov 2000 | A |
6143014 | Dehdashtian et al. | Nov 2000 | A |
6143015 | Nobles | Nov 2000 | A |
6143016 | Bleam et al. | Nov 2000 | A |
6143021 | Staehle | Nov 2000 | A |
6143022 | Shull et al. | Nov 2000 | A |
6146389 | Geitz | Nov 2000 | A |
6146416 | Andersen et al. | Nov 2000 | A |
6146417 | Ischinger | Nov 2000 | A |
6149665 | Gabbay | Nov 2000 | A |
6149681 | Houser et al. | Nov 2000 | A |
6149682 | Frid | Nov 2000 | A |
6152944 | Holman et al. | Nov 2000 | A |
6152956 | Pierce | Nov 2000 | A |
6156063 | Douglas | Dec 2000 | A |
6156064 | Chouinard | Dec 2000 | A |
6159229 | Jendersee et al. | Dec 2000 | A |
6159237 | Alt et al. | Dec 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6159565 | Campbell et al. | Dec 2000 | A |
6162243 | Gray et al. | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6162246 | Barone | Dec 2000 | A |
6165210 | Lau et al. | Dec 2000 | A |
6165211 | Thompson | Dec 2000 | A |
6165212 | Dereume et al. | Dec 2000 | A |
6165213 | Goicoechea et al. | Dec 2000 | A |
6165214 | Lazarus | Dec 2000 | A |
6168610 | Marin et al. | Jan 2001 | B1 |
6168614 | Andersen et al. | Jan 2001 | B1 |
6168616 | Brown, III | Jan 2001 | B1 |
6168617 | Blaeser et al. | Jan 2001 | B1 |
6168618 | Frantzen | Jan 2001 | B1 |
6168619 | Dinh et al. | Jan 2001 | B1 |
6168620 | Kerr | Jan 2001 | B1 |
6174326 | Kitaoka et al. | Jan 2001 | B1 |
6183481 | Lee et al. | Feb 2001 | B1 |
6183504 | Inoue | Feb 2001 | B1 |
6187034 | Frantzen | Feb 2001 | B1 |
6187036 | Shaolian et al. | Feb 2001 | B1 |
6187054 | Colone et al. | Feb 2001 | B1 |
6193745 | Fogarty et al. | Feb 2001 | B1 |
6196230 | Hall et al. | Mar 2001 | B1 |
6197046 | Piplani et al. | Mar 2001 | B1 |
6197049 | Shaolian et al. | Mar 2001 | B1 |
6200339 | Leschinsky et al. | Mar 2001 | B1 |
6203550 | Olson | Mar 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6203735 | Edwin et al. | Mar 2001 | B1 |
6203779 | Ricci et al. | Mar 2001 | B1 |
6210422 | Douglas | Apr 2001 | B1 |
6210434 | Quiachon et al. | Apr 2001 | B1 |
6210435 | Piplani et al. | Apr 2001 | B1 |
6214038 | Piplani et al. | Apr 2001 | B1 |
6214039 | Banas et al. | Apr 2001 | B1 |
6217608 | Penn et al. | Apr 2001 | B1 |
6221102 | Baker et al. | Apr 2001 | B1 |
6224609 | Ressemann et al. | May 2001 | B1 |
6231562 | Khosravi et al. | May 2001 | B1 |
6235050 | Quiachon et al. | May 2001 | B1 |
6235051 | Murphy | May 2001 | B1 |
6238432 | Parodi | May 2001 | B1 |
6240616 | Yan | Jun 2001 | B1 |
6241759 | Piplani et al. | Jun 2001 | B1 |
6245097 | Inoue | Jun 2001 | B1 |
6245099 | Edwin et al. | Jun 2001 | B1 |
6245100 | Davila et al. | Jun 2001 | B1 |
6245101 | Drasler et al. | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6248116 | Chevillon et al. | Jun 2001 | B1 |
6251132 | Ravenscroft et al. | Jun 2001 | B1 |
6251136 | Guruwaiya et al. | Jun 2001 | B1 |
6254593 | Wilson | Jul 2001 | B1 |
6254632 | Wu et al. | Jul 2001 | B1 |
6258073 | Mauch | Jul 2001 | B1 |
6258114 | Konya et al. | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6261316 | Shaolian et al. | Jul 2001 | B1 |
6261317 | Inoue | Jul 2001 | B1 |
6264662 | Lauterjung | Jul 2001 | B1 |
6264684 | Banas et al. | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6267834 | Shannon et al. | Jul 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6270525 | Letendre et al. | Aug 2001 | B1 |
6270707 | Hon et al. | Aug 2001 | B1 |
6273909 | Kugler et al. | Aug 2001 | B1 |
6273910 | Limon | Aug 2001 | B1 |
6273911 | Cox et al. | Aug 2001 | B1 |
6280457 | Wallace et al. | Aug 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6280467 | Leonhardt et al. | Aug 2001 | B1 |
6283991 | Cox et al. | Sep 2001 | B1 |
6287315 | Wijeratne et al. | Sep 2001 | B1 |
6287329 | Duerig et al. | Sep 2001 | B1 |
6287330 | Johansson et al. | Sep 2001 | B1 |
6287335 | Drasler et al. | Sep 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6290728 | Phelps et al. | Sep 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6293968 | Taheri | Sep 2001 | B1 |
6293969 | Chuter | Sep 2001 | B1 |
6296661 | Davila et al. | Oct 2001 | B1 |
6302891 | Nadal | Oct 2001 | B1 |
6302905 | Goldsteen et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6302908 | Parodi | Oct 2001 | B1 |
6303100 | Ricci et al. | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6306145 | Leschinsky | Oct 2001 | B1 |
6306164 | Kujawski | Oct 2001 | B1 |
6306165 | Patnaik et al. | Oct 2001 | B1 |
6312458 | Golds | Nov 2001 | B1 |
6312460 | Drasler et al. | Nov 2001 | B2 |
6312462 | McDermott et al. | Nov 2001 | B1 |
6315791 | Gingras et al. | Nov 2001 | B1 |
6319276 | Holman et al. | Nov 2001 | B1 |
6319278 | Quinn | Nov 2001 | B1 |
6319279 | Shannon et al. | Nov 2001 | B1 |
6322587 | Quiachon et al. | Nov 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6325823 | Horzewski et al. | Dec 2001 | B1 |
6325824 | Limon | Dec 2001 | B2 |
6325825 | Kula et al. | Dec 2001 | B1 |
6328762 | Anderson et al. | Dec 2001 | B1 |
6331186 | Wang et al. | Dec 2001 | B1 |
6331188 | Lau et al. | Dec 2001 | B1 |
6331190 | Shokoohi et al. | Dec 2001 | B1 |
6331191 | Chobotov | Dec 2001 | B1 |
6334869 | Leonhardt et al. | Jan 2002 | B1 |
6336937 | Vonesh et al. | Jan 2002 | B1 |
6344044 | Fulkerson et al. | Feb 2002 | B1 |
6344054 | Parodi | Feb 2002 | B1 |
6344055 | Shukov | Feb 2002 | B1 |
6346118 | Baker et al. | Feb 2002 | B1 |
6346119 | Kuwahara et al. | Feb 2002 | B1 |
6348065 | Brown et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352553 | Van der Burg et al. | Mar 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6355055 | Waksman et al. | Mar 2002 | B1 |
6355056 | Pnheiro | Mar 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6355063 | Calcote | Mar 2002 | B1 |
6357104 | Myers | Mar 2002 | B1 |
6358276 | Edwin et al. | Mar 2002 | B1 |
6358284 | Fearnot et al. | Mar 2002 | B1 |
6361637 | Martin et al. | Mar 2002 | B2 |
6363938 | Saadat | Apr 2002 | B2 |
6364856 | Ding et al. | Apr 2002 | B1 |
6364904 | Smith | Apr 2002 | B1 |
6368346 | Jadhav | Apr 2002 | B1 |
6368347 | Maini et al. | Apr 2002 | B1 |
6368355 | Uflacker | Apr 2002 | B1 |
6371979 | Beyar et al. | Apr 2002 | B1 |
6372136 | Nakatsuka | Apr 2002 | B1 |
6375787 | Lukic | Apr 2002 | B1 |
6379381 | Hossainy et al. | Apr 2002 | B1 |
6379382 | Yang | Apr 2002 | B1 |
6379392 | Walak | Apr 2002 | B1 |
6383213 | Wilson et al. | May 2002 | B2 |
6383214 | Banas et al. | May 2002 | B1 |
6387119 | Wolf et al. | May 2002 | B2 |
6387124 | Buscemi et al. | May 2002 | B1 |
6391050 | Broome | May 2002 | B1 |
6391052 | Buirge et al. | May 2002 | B2 |
6395019 | Chobotov | May 2002 | B2 |
6395022 | Piplani et al. | May 2002 | B1 |
6395208 | Herweck et al. | May 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6402779 | Colone et al. | Jun 2002 | B1 |
6406489 | Richter et al. | Jun 2002 | B1 |
6409749 | Maynard | Jun 2002 | B1 |
6409750 | Hyodoh | Jun 2002 | B1 |
6409754 | Smith et al. | Jun 2002 | B1 |
6409756 | Murphy | Jun 2002 | B1 |
6409757 | Trout et al. | Jun 2002 | B1 |
6409761 | Jang | Jun 2002 | B1 |
6413269 | Bui et al. | Jul 2002 | B1 |
6416535 | Lazarus | Jul 2002 | B1 |
6416536 | Yee | Jul 2002 | B1 |
6416537 | Martakos et al. | Jul 2002 | B1 |
6416538 | Ley et al. | Jul 2002 | B1 |
6416539 | Hassdenteufel | Jul 2002 | B1 |
6416542 | Marcade et al. | Jul 2002 | B1 |
6419701 | Cook et al. | Jul 2002 | B1 |
6423084 | St. Germain | Jul 2002 | B1 |
6423089 | Gingras et al. | Jul 2002 | B1 |
6423090 | Hancock | Jul 2002 | B1 |
6425855 | Tomonto | Jul 2002 | B2 |
6425898 | Wilson et al. | Jul 2002 | B1 |
6428506 | Simhambhatla et al. | Aug 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6428566 | Holt | Aug 2002 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6428569 | Brown | Aug 2002 | B1 |
6428570 | Globerman | Aug 2002 | B1 |
6428571 | Lentz et al. | Aug 2002 | B1 |
6432129 | DiCaprio | Aug 2002 | B2 |
6432131 | Ravenscroft | Aug 2002 | B1 |
6432132 | Cottone et al. | Aug 2002 | B1 |
6436104 | Hoieibane | Aug 2002 | B2 |
6436133 | Furst et al. | Aug 2002 | B1 |
6436134 | Richter et al. | Aug 2002 | B2 |
6436135 | Goldfarb | Aug 2002 | B1 |
6440165 | Richter et al. | Aug 2002 | B1 |
6443941 | Slepian et al. | Sep 2002 | B1 |
6443979 | Stalker et al. | Sep 2002 | B1 |
6443981 | Colone et al. | Sep 2002 | B1 |
6447501 | Solar et al. | Sep 2002 | B1 |
6447522 | Gambale et al. | Sep 2002 | B2 |
6451047 | McCrea et al. | Sep 2002 | B2 |
6451050 | Rudakov et al. | Sep 2002 | B1 |
6451051 | Drasler et al. | Sep 2002 | B2 |
6451053 | Dehdashtian et al. | Sep 2002 | B1 |
6454796 | Barkman et al. | Sep 2002 | B1 |
6461381 | Israel et al. | Oct 2002 | B2 |
6464720 | Boatman et al. | Oct 2002 | B2 |
6464721 | Marcade et al. | Oct 2002 | B1 |
6464722 | Israel et al. | Oct 2002 | B2 |
6471718 | Staehle et al. | Oct 2002 | B1 |
6471720 | Ehr et al. | Oct 2002 | B1 |
6471721 | Dang | Oct 2002 | B1 |
6471722 | Inoue | Oct 2002 | B1 |
6475166 | Escano | Nov 2002 | B1 |
6475208 | Mauch | Nov 2002 | B2 |
6475236 | Roubin et al. | Nov 2002 | B1 |
6475237 | Drasler | Nov 2002 | B2 |
6475238 | Fedida | Nov 2002 | B1 |
6475466 | Ricci et al. | Nov 2002 | B1 |
6478807 | Foreman et al. | Nov 2002 | B1 |
6478815 | Alt | Nov 2002 | B1 |
6478816 | Kveen et al. | Nov 2002 | B1 |
6482227 | Solovay | Nov 2002 | B1 |
6485507 | Walak et al. | Nov 2002 | B1 |
6485508 | McGuinness | Nov 2002 | B1 |
6485509 | Killion et al. | Nov 2002 | B2 |
6485511 | Lau et al. | Nov 2002 | B2 |
6485513 | Fan | Nov 2002 | B1 |
6485515 | Strecker | Nov 2002 | B2 |
6485524 | Strecker | Nov 2002 | B2 |
6488694 | Lau et al. | Dec 2002 | B1 |
6488700 | Klumb et al. | Dec 2002 | B2 |
6488701 | Nolting et al. | Dec 2002 | B1 |
6488705 | Schmitt et al. | Dec 2002 | B2 |
6491718 | Ahmad | Dec 2002 | B1 |
6491719 | Fogary et al. | Dec 2002 | B1 |
6494875 | Mauch | Dec 2002 | B1 |
6494904 | Love | Dec 2002 | B1 |
6494907 | Bulver | Dec 2002 | B1 |
6494909 | Greenhalgh | Dec 2002 | B2 |
6497722 | Von Oepen et al. | Dec 2002 | B1 |
6497723 | Starck et al. | Dec 2002 | B1 |
6500202 | Shaolian et al. | Dec 2002 | B1 |
6500203 | Thompson et al. | Dec 2002 | B1 |
6500204 | Igaki | Dec 2002 | B1 |
6500532 | Ruefer et al. | Dec 2002 | B1 |
6503271 | Duerig et al. | Jan 2003 | B2 |
6506211 | Doran et al. | Jan 2003 | B1 |
6508833 | Pavcnik et al. | Jan 2003 | B2 |
6508834 | Pinchasik et al. | Jan 2003 | B1 |
6514281 | Blaeser et al. | Feb 2003 | B1 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6517571 | Brauker et al. | Feb 2003 | B1 |
6517573 | Pollock et al. | Feb 2003 | B1 |
6517574 | Chuter | Feb 2003 | B1 |
6520983 | Colgan et al. | Feb 2003 | B1 |
6520984 | Garrison et al. | Feb 2003 | B1 |
6520986 | Martin et al. | Feb 2003 | B2 |
6524334 | Thompson | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6524336 | Papazolgou et al. | Feb 2003 | B1 |
6530765 | Zdrahala et al. | Mar 2003 | B1 |
6530947 | Euteneuer et al. | Mar 2003 | B1 |
6530950 | Alvarado et al. | Mar 2003 | B1 |
6533806 | Sullivan et al. | Mar 2003 | B1 |
6533807 | Wolinsky et al. | Mar 2003 | B2 |
6533808 | Thompson et al. | Mar 2003 | B1 |
6533811 | Ryan et al. | Mar 2003 | B1 |
6537202 | Frantzen | Mar 2003 | B1 |
6540778 | Quiachon et al. | Apr 2003 | B1 |
6540780 | Zilla et al. | Apr 2003 | B1 |
6547813 | Stiger et al. | Apr 2003 | B2 |
6547814 | Edwin et al. | Apr 2003 | B2 |
6547815 | Myers | Apr 2003 | B2 |
6547817 | Fischell et al. | Apr 2003 | B1 |
6548013 | Kadavy et al. | Apr 2003 | B2 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6554857 | Zilla et al. | Apr 2003 | B1 |
6554858 | Dereume et al. | Apr 2003 | B2 |
6558414 | Layne | May 2003 | B2 |
6558415 | Thompson | May 2003 | B2 |
6562063 | Euteneuer et al. | May 2003 | B1 |
6565597 | Fearnot | May 2003 | B1 |
6569150 | Teague | May 2003 | B2 |
6569190 | Whalen, II et al. | May 2003 | B2 |
6569193 | Cox et al. | May 2003 | B1 |
6572649 | Berry et al. | Jun 2003 | B2 |
6575994 | Marin | Jun 2003 | B1 |
6576009 | Ryan et al. | Jun 2003 | B2 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6582458 | White et al. | Jun 2003 | B1 |
6589274 | Stiger et al. | Jul 2003 | B2 |
6589275 | Ivancev et al. | Jul 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6602269 | Wallace et al. | Aug 2003 | B2 |
6602280 | Chobotov | Aug 2003 | B2 |
6602283 | Doran et al. | Aug 2003 | B2 |
6605110 | Harrison | Aug 2003 | B2 |
6607551 | Sullivan et al. | Aug 2003 | B1 |
6613082 | Yang | Sep 2003 | B2 |
6613083 | Alt | Sep 2003 | B2 |
6613084 | Yang | Sep 2003 | B2 |
6620190 | Colone | Sep 2003 | B1 |
6626938 | Butaric et al. | Sep 2003 | B1 |
6635079 | Unsworth et al. | Oct 2003 | B2 |
6645240 | Yee | Nov 2003 | B2 |
6652554 | Wholey et al. | Nov 2003 | B1 |
6652570 | Smith et al. | Nov 2003 | B2 |
6652573 | Oepen | Nov 2003 | B2 |
6652575 | Wang | Nov 2003 | B2 |
6652580 | Chutter | Nov 2003 | B1 |
6656215 | Yanez et al. | Dec 2003 | B1 |
6656506 | Wu et al. | Dec 2003 | B1 |
6660030 | Shaolian et al. | Dec 2003 | B2 |
6663662 | Pacetti et al. | Dec 2003 | B2 |
6663663 | Kim et al. | Dec 2003 | B2 |
6663664 | Pacitti | Dec 2003 | B1 |
6663665 | Shaolian et al. | Dec 2003 | B2 |
6663667 | Dehdashtian et al. | Dec 2003 | B2 |
6669720 | Pierce | Dec 2003 | B1 |
6669723 | Killion et al. | Dec 2003 | B2 |
6669724 | Park et al. | Dec 2003 | B2 |
6673102 | Vonesh et al. | Jan 2004 | B1 |
6673103 | Golds et al. | Jan 2004 | B1 |
6673106 | Mitelberg et al. | Jan 2004 | B2 |
6673107 | Brandt et al. | Jan 2004 | B1 |
6676667 | Mareiro et al. | Jan 2004 | B2 |
6676695 | Solem | Jan 2004 | B2 |
6679911 | Burgermeister | Jan 2004 | B2 |
6685736 | White et al. | Feb 2004 | B1 |
6689158 | White et al. | Feb 2004 | B1 |
6689159 | Hartigan et al. | Feb 2004 | B2 |
6692523 | Holman et al. | Feb 2004 | B2 |
6694983 | Hall et al. | Feb 2004 | B2 |
6695833 | Frantzen | Feb 2004 | B1 |
6695875 | Stelter et al. | Feb 2004 | B2 |
6695877 | Brucker et al. | Feb 2004 | B2 |
6696666 | Merdan et al. | Feb 2004 | B2 |
6699274 | Stinson | Mar 2004 | B2 |
6699277 | Freidberg et al. | Mar 2004 | B1 |
6702847 | DiCarlo | Mar 2004 | B2 |
6702849 | Dutta et al. | Mar 2004 | B1 |
6706064 | Anson | Mar 2004 | B1 |
6709449 | Camrud et al. | Mar 2004 | B2 |
6709455 | Chouinard | Mar 2004 | B1 |
6712827 | Ellis et al. | Mar 2004 | B2 |
6716238 | Elliott | Apr 2004 | B2 |
6716239 | Sowinski | Apr 2004 | B2 |
6719783 | Lentz et al. | Apr 2004 | B2 |
6726712 | Raeder-Devens | Apr 2004 | B1 |
6730119 | Smalling | May 2004 | B1 |
6733521 | Chobotov et al. | May 2004 | B2 |
6736839 | Cummings | May 2004 | B2 |
6740111 | Lauterjung | May 2004 | B1 |
6740114 | Burgermeister | May 2004 | B2 |
6740115 | Lombardi | May 2004 | B2 |
6743210 | Hart et al. | Jun 2004 | B2 |
6743511 | Dittrich et al. | Jun 2004 | B2 |
6746890 | Gupta | Jun 2004 | B2 |
6752829 | Kocur et al. | Jun 2004 | B2 |
6755855 | Yurek et al. | Jun 2004 | B2 |
6758858 | McCrea et al. | Jul 2004 | B2 |
6761733 | Chobotov et al. | Jul 2004 | B2 |
6770086 | Girton et al. | Aug 2004 | B1 |
6770087 | Layne et al. | Aug 2004 | B2 |
6773453 | Ravenscroft | Aug 2004 | B2 |
6773457 | Ivancev et al. | Aug 2004 | B2 |
6776604 | Chobotov et al. | Aug 2004 | B1 |
6776793 | Brown et al. | Aug 2004 | B2 |
6786920 | Shannon et al. | Sep 2004 | B2 |
6790227 | Burgermeister | Sep 2004 | B2 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6793672 | Khosravi et al. | Sep 2004 | B2 |
6796999 | Pinchasik | Sep 2004 | B2 |
6802849 | Blaeser et al. | Oct 2004 | B2 |
6802856 | Wilson | Oct 2004 | B2 |
6814753 | Schmitt | Nov 2004 | B2 |
6818013 | Mitelberg et al. | Nov 2004 | B2 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6824558 | Parodi | Nov 2004 | B2 |
6827726 | Parodi | Dec 2004 | B2 |
6827731 | Annstrong et al. | Dec 2004 | B2 |
6827735 | Greenbeg | Dec 2004 | B2 |
6827737 | Hill et al. | Dec 2004 | B2 |
6833004 | Ishil et al. | Dec 2004 | B2 |
6841213 | Parsonage et al. | Jan 2005 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6849086 | Cragg | Feb 2005 | B2 |
6858035 | Whayne | Feb 2005 | B2 |
6860900 | Clerc et al. | Mar 2005 | B2 |
6863685 | Davila et al. | Mar 2005 | B2 |
6869443 | Buscemi et al. | Mar 2005 | B2 |
6878160 | Gilligan et al. | Apr 2005 | B2 |
6878161 | Lenker | Apr 2005 | B2 |
6884260 | Kugler et al. | Apr 2005 | B2 |
6899728 | Phillips et al. | May 2005 | B1 |
6918925 | Tehrani | Jul 2005 | B2 |
6918927 | Bates et al. | Jul 2005 | B2 |
6923827 | Campbell et al. | Aug 2005 | B2 |
6926732 | Derus et al. | Aug 2005 | B2 |
6929659 | Pinchuk | Aug 2005 | B2 |
6929709 | Smith | Aug 2005 | B2 |
6939370 | Hartley et al. | Sep 2005 | B2 |
6939374 | Banik et al. | Sep 2005 | B2 |
6942689 | Majercak | Sep 2005 | B2 |
6945989 | Betelia et al. | Sep 2005 | B1 |
6945992 | Goodson et al. | Sep 2005 | B2 |
6949120 | Kveen et al. | Sep 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
6962603 | Brown | Nov 2005 | B1 |
6964677 | Osypka | Nov 2005 | B2 |
6974471 | Van Schie et al. | Dec 2005 | B2 |
6974472 | Hong et al. | Dec 2005 | B2 |
6981982 | Armstrong et al. | Jan 2006 | B2 |
6989026 | Richter et al. | Jan 2006 | B2 |
6994722 | DiCarlo | Feb 2006 | B2 |
6997945 | Germain | Feb 2006 | B2 |
6998060 | Tomonto | Feb 2006 | B2 |
7001407 | Hansen et al. | Feb 2006 | B2 |
7001419 | DiCaprio et al. | Feb 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7011673 | Fischell et al. | Mar 2006 | B2 |
7011674 | Brenneman | Mar 2006 | B2 |
7022132 | Kocur | Apr 2006 | B2 |
7022135 | Zilla et al. | Apr 2006 | B2 |
7033389 | Sherry | Apr 2006 | B2 |
7056325 | Makower | Jun 2006 | B1 |
7056336 | Armstrong et al. | Jun 2006 | B2 |
7056412 | Henderson | Jun 2006 | B2 |
7066951 | Chobotov | Jun 2006 | B2 |
7073504 | Callister et al. | Jul 2006 | B2 |
7081129 | Chobotov | Jul 2006 | B2 |
7081132 | Cook | Jul 2006 | B2 |
7083642 | Sirhan et al. | Aug 2006 | B2 |
7090693 | Chobotov et al. | Aug 2006 | B1 |
7094255 | Penn et al. | Aug 2006 | B2 |
7108715 | Brown et al. | Sep 2006 | B2 |
7115140 | Stoltze et al. | Oct 2006 | B2 |
7125464 | Chobotov et al. | Oct 2006 | B2 |
7128754 | Bolduc | Oct 2006 | B2 |
7128755 | Su et al. | Oct 2006 | B2 |
7147455 | Chobotov et al. | Dec 2006 | B2 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7147661 | Chobotov et al. | Dec 2006 | B2 |
7150758 | Kari et al. | Dec 2006 | B2 |
7160318 | Greenberg et al. | Jan 2007 | B2 |
7166125 | Baker et al. | Jan 2007 | B1 |
7175651 | Kerr | Feb 2007 | B2 |
7175652 | Cook et al. | Feb 2007 | B2 |
7189256 | Smith | Mar 2007 | B2 |
7192441 | Sherry | Mar 2007 | B2 |
7223280 | Anson et al. | May 2007 | B2 |
7226474 | Iancea et al. | Jun 2007 | B2 |
7229470 | Brian et al. | Jun 2007 | B2 |
7232459 | Greenberg | Jun 2007 | B2 |
7244242 | Freyman | Jul 2007 | B2 |
7273494 | Rolando et al. | Sep 2007 | B2 |
7284399 | Sisco | Oct 2007 | B1 |
7294147 | Hartley | Nov 2007 | B2 |
7314484 | Deem et al. | Jan 2008 | B2 |
7318835 | Berra | Jan 2008 | B2 |
7338518 | Chobotov | Mar 2008 | B2 |
7351256 | Hojeibane et al. | Apr 2008 | B2 |
7425219 | Quadri | Sep 2008 | B2 |
7452374 | Hain et al. | Nov 2008 | B2 |
7465270 | Li | Dec 2008 | B2 |
7485138 | Fearnot et al. | Feb 2009 | B2 |
7491230 | Holman et al. | Feb 2009 | B2 |
7491234 | Palasis et al. | Feb 2009 | B2 |
7500988 | Butaric et al. | Mar 2009 | B1 |
7510571 | Spiridiglozzi et al. | Mar 2009 | B2 |
7520890 | Phillips | Apr 2009 | B2 |
7520895 | Douglas et al. | Apr 2009 | B2 |
7530988 | Evans et al. | May 2009 | B2 |
7550004 | Bahaler et al. | Jun 2009 | B2 |
7550005 | Bates et al. | Jun 2009 | B2 |
7556645 | Lashinski et al. | Jul 2009 | B2 |
7591843 | Escano | Sep 2009 | B1 |
7597710 | Obermiller | Oct 2009 | B2 |
7766954 | Chobotov et al. | Aug 2010 | B2 |
7976575 | Hartley | Jul 2011 | B2 |
8043356 | Kolbel et al. | Oct 2011 | B2 |
8066755 | Zacharias et al. | Nov 2011 | B2 |
8252036 | Cartledge et al. | Aug 2012 | B2 |
20010014794 | Moll | Aug 2001 | A1 |
20010029349 | Leschinsky | Oct 2001 | A1 |
20010039445 | Hall et al. | Nov 2001 | A1 |
20010041928 | Pavcnik et al. | Nov 2001 | A1 |
20010044652 | Moore | Nov 2001 | A1 |
20010049534 | Lachat | Dec 2001 | A1 |
20020007193 | Tanner et al. | Jan 2002 | A1 |
20020011684 | Bahar et al. | Jan 2002 | A1 |
20020016626 | DiMatteo et al. | Feb 2002 | A1 |
20020019659 | Goicoechea et al. | Feb 2002 | A1 |
20020029051 | Callister et al. | Mar 2002 | A1 |
20020032408 | Parker et al. | Mar 2002 | A1 |
20020035395 | Sigimoto | Mar 2002 | A1 |
20020040236 | Lau et al. | Apr 2002 | A1 |
20020040237 | Lentz et al. | Apr 2002 | A1 |
20020042644 | Greenhalgh | Apr 2002 | A1 |
20020045931 | Sogard et al. | Apr 2002 | A1 |
20020045933 | Jang | Apr 2002 | A1 |
20020045934 | Jang | Apr 2002 | A1 |
20020045935 | Jang | Apr 2002 | A1 |
20020049487 | Lootz et al. | Apr 2002 | A1 |
20020049490 | Pollock et al. | Apr 2002 | A1 |
20020049493 | Jang | Apr 2002 | A1 |
20020052627 | Boylan et al. | May 2002 | A1 |
20020052644 | Shaolin et al. | May 2002 | A1 |
20020052649 | Greenhalgh | May 2002 | A1 |
20020055768 | Hess et al. | May 2002 | A1 |
20020065552 | Jayaraman et al. | May 2002 | A1 |
20020072792 | Burgermeister et al. | Jun 2002 | A1 |
20020072793 | Rolando et al. | Jun 2002 | A1 |
20020076542 | Kramer et al. | Jun 2002 | A1 |
20020077692 | Besselink | Jun 2002 | A1 |
20020082680 | Stanley et al. | Jun 2002 | A1 |
20020082682 | Barclay et al. | Jun 2002 | A1 |
20020082685 | Sirhan et al. | Jun 2002 | A1 |
20020095208 | Gregorich et al. | Jul 2002 | A1 |
20020096252 | Lukic | Jul 2002 | A1 |
20020107561 | Pinheiro | Aug 2002 | A1 |
20020116050 | Kocur | Aug 2002 | A1 |
20020120321 | Gunderson et al. | Aug 2002 | A1 |
20020120327 | Cox et al. | Aug 2002 | A1 |
20020123790 | White et al. | Sep 2002 | A1 |
20020123791 | Harrison | Sep 2002 | A1 |
20020123796 | Majercak et al. | Sep 2002 | A1 |
20020143387 | Soetikno et al. | Oct 2002 | A1 |
20020147492 | Shokoohi et al. | Oct 2002 | A1 |
20020151953 | Chobotov et al. | Oct 2002 | A1 |
20020151956 | Chobotov et al. | Oct 2002 | A1 |
20020156522 | Ryan et al. | Oct 2002 | A1 |
20020161376 | Barry et al. | Oct 2002 | A1 |
20020165603 | Thornton et al. | Nov 2002 | A1 |
20020169497 | Wholey et al. | Nov 2002 | A1 |
20020183826 | Dorn et al. | Dec 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20020188344 | Bolea et al. | Dec 2002 | A1 |
20020188346 | Healy et al. | Dec 2002 | A1 |
20020188347 | Mathis | Dec 2002 | A1 |
20020193867 | Gladdish, Jr. et al. | Dec 2002 | A1 |
20020193872 | Trout et al. | Dec 2002 | A1 |
20020193873 | Brucker et al. | Dec 2002 | A1 |
20020198585 | Wisselink | Dec 2002 | A1 |
20020198587 | Greenberg et al. | Dec 2002 | A1 |
20030004560 | Chobotov et al. | Jan 2003 | A1 |
20030004565 | Harnek et al. | Jan 2003 | A1 |
20030009212 | Kerr | Jan 2003 | A1 |
20030014075 | Rosenbluth et al. | Jan 2003 | A1 |
20030033001 | Igaki | Feb 2003 | A1 |
20030040803 | Rioux et al. | Feb 2003 | A1 |
20030050684 | Abrams et al. | Mar 2003 | A1 |
20030068296 | Ricci et al. | Apr 2003 | A1 |
20030074050 | Kerr | Apr 2003 | A1 |
20030083736 | Brown et al. | May 2003 | A1 |
20030088305 | Van Schie et al. | May 2003 | A1 |
20030097170 | Friedrich et al. | May 2003 | A1 |
20030116260 | Chobotov et al. | Jun 2003 | A1 |
20030120263 | Ouriel et al. | Jun 2003 | A1 |
20030120331 | Chobotov et al. | Jun 2003 | A1 |
20030125797 | Chobotov | Jul 2003 | A1 |
20030135256 | Gallagher et al. | Jul 2003 | A1 |
20030135261 | Kugler et al. | Jul 2003 | A1 |
20030176912 | Chuter et al. | Sep 2003 | A1 |
20030191518 | Spiridiglozzi et al. | Oct 2003 | A1 |
20030204236 | Letort | Oct 2003 | A1 |
20030204244 | Stiger | Oct 2003 | A1 |
20030212449 | Cox | Nov 2003 | A1 |
20030220683 | Minasian | Nov 2003 | A1 |
20030225453 | Murch | Dec 2003 | A1 |
20040024446 | Smith | Feb 2004 | A1 |
20040034407 | Sherry | Feb 2004 | A1 |
20040044395 | Nelson | Mar 2004 | A1 |
20040049212 | Whayne | Mar 2004 | A1 |
20040049264 | Sowinski et al. | Mar 2004 | A1 |
20040093055 | Bartorelli et al. | May 2004 | A1 |
20040093064 | Bosma | May 2004 | A1 |
20040093068 | Bergen et al. | May 2004 | A1 |
20040093078 | Moll et al. | May 2004 | A1 |
20040098096 | Eton | May 2004 | A1 |
20040106974 | Greenberg et al. | Jun 2004 | A1 |
20040116997 | Taylor et al. | Jun 2004 | A1 |
20040138734 | Chobotov et al. | Jul 2004 | A1 |
20040148008 | Goodson et al. | Jul 2004 | A1 |
20040162607 | Masroor | Aug 2004 | A1 |
20040167614 | Anson | Aug 2004 | A1 |
20040176836 | Chobotov | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040215213 | Dolan | Oct 2004 | A1 |
20040220655 | Swanson et al. | Nov 2004 | A1 |
20040220664 | Chobotov | Nov 2004 | A1 |
20040254625 | Stephens | Dec 2004 | A1 |
20050033406 | Barnhart et al. | Feb 2005 | A1 |
20050049674 | Berra et al. | Mar 2005 | A1 |
20050049691 | Mercile et al. | Mar 2005 | A1 |
20050075715 | Borges et al. | Apr 2005 | A1 |
20050090804 | Chobotov et al. | Apr 2005 | A1 |
20050090901 | Studer | Apr 2005 | A1 |
20050154443 | Linder et al. | Jul 2005 | A1 |
20050158272 | Whirley et al. | Jul 2005 | A1 |
20050171593 | Whirley et al. | Aug 2005 | A1 |
20050177222 | Mead | Aug 2005 | A1 |
20050222669 | Purdy | Oct 2005 | A1 |
20050228484 | Stephens et al. | Oct 2005 | A1 |
20060009833 | Chobotov et al. | Jan 2006 | A1 |
20060020319 | Kim | Jan 2006 | A1 |
20060030921 | Berra | Feb 2006 | A1 |
20060079952 | Kaplan et al. | Apr 2006 | A1 |
20060136047 | Obermiller et al. | Jun 2006 | A1 |
20060149364 | Walak et al. | Jul 2006 | A1 |
20060161244 | Seguin | Jul 2006 | A1 |
20060178732 | Chobotov et al. | Aug 2006 | A1 |
20060186143 | Argentine | Aug 2006 | A1 |
20060212112 | Evans et al. | Sep 2006 | A1 |
20060224232 | Chobotov | Oct 2006 | A1 |
20060233990 | Humphrey et al. | Oct 2006 | A1 |
20060233991 | Humphrey et al. | Oct 2006 | A1 |
20060287713 | Douglas et al. | Dec 2006 | A1 |
20060292206 | Kim et al. | Dec 2006 | A1 |
20070012396 | Chobotov et al. | Jan 2007 | A1 |
20070016281 | Melsheimer | Jan 2007 | A1 |
20070055347 | Arbeferize | Mar 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070112413 | Smith | May 2007 | A1 |
20070162106 | Evans et al. | Jul 2007 | A1 |
20070167901 | Herrig et al. | Jul 2007 | A1 |
20070203571 | Kaplan et al. | Aug 2007 | A1 |
20070219627 | Chu et al. | Sep 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244539 | Lentz et al. | Oct 2007 | A1 |
20070276477 | Lee et al. | Nov 2007 | A1 |
20070282369 | Gilson et al. | Dec 2007 | A1 |
20080015687 | Lashinski et al. | Jan 2008 | A1 |
20080027529 | Hartley et al. | Jan 2008 | A1 |
20080051705 | Von Oepen et al. | Feb 2008 | A1 |
20080058920 | Kari | Mar 2008 | A1 |
20080114441 | Rust | May 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080114443 | Mitchell | May 2008 | A1 |
20080132995 | Burgermeister et al. | Jun 2008 | A1 |
20080172119 | Yamasaki et al. | Jul 2008 | A1 |
20080228255 | Rust | Sep 2008 | A1 |
20090005854 | Huang et al. | Jan 2009 | A1 |
20090036971 | Humphrey et al. | Feb 2009 | A1 |
20090042796 | Wallach et al. | Feb 2009 | A1 |
20090082841 | Zacharias et al. | Mar 2009 | A1 |
20090082842 | Glynn | Mar 2009 | A1 |
20090082844 | Chobotov et al. | Mar 2009 | A1 |
20090082845 | Chobotov et al. | Mar 2009 | A1 |
20090082846 | Chobotov et al. | Mar 2009 | A1 |
20090082847 | Zacharias et al. | Mar 2009 | A1 |
20090099649 | Chobotov et al. | Apr 2009 | A1 |
20090132020 | Watson | May 2009 | A1 |
20090132026 | Martin et al. | May 2009 | A1 |
20090171431 | Swanson et al. | Jul 2009 | A1 |
20090182406 | Blaeser et al. | Jul 2009 | A1 |
20090198267 | Evans et al. | Aug 2009 | A1 |
20090287145 | Cragg et al. | Nov 2009 | A1 |
20090287290 | Macaulay et al. | Nov 2009 | A1 |
20100114290 | Rasmussen et al. | May 2010 | A1 |
20100161028 | Chuter et al. | Jun 2010 | A1 |
20100211052 | Brown et al. | Aug 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100305686 | Cragg | Dec 2010 | A1 |
20100331958 | Chobotov et al. | Dec 2010 | A1 |
20110130819 | Cragg | Jun 2011 | A1 |
20110130820 | Cragg | Jun 2011 | A1 |
20110130824 | Cragg | Jun 2011 | A1 |
20110130825 | Cragg | Jun 2011 | A1 |
20110130826 | Cragg | Jun 2011 | A1 |
20110218609 | Chobotov et al. | Sep 2011 | A1 |
20110238160 | Molony | Sep 2011 | A1 |
20120016457 | Chobotov et al. | Jan 2012 | A1 |
20120041543 | Huang et al. | Feb 2012 | A1 |
20120130469 | Cragg | May 2012 | A1 |
20120191174 | Vinluan et al. | Jul 2012 | A1 |
20120197384 | Lee et al. | Aug 2012 | A1 |
20130090715 | Chobotov et al. | Apr 2013 | A1 |
20130268044 | Parsons et al. | Oct 2013 | A1 |
20130268048 | Watson et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
2438087 | Mar 2001 | CA |
19624642 | Jan 1998 | DE |
0646365 | Apr 1995 | EP |
0714641 | Jun 1996 | EP |
0775472 | May 1997 | EP |
0792627 | Sep 1997 | EP |
0808613 | Nov 1997 | EP |
0819411 | Jan 1998 | EP |
0878175 | Nov 1998 | EP |
0943302 | Sep 1999 | EP |
0997115 | May 2000 | EP |
0480667 | Apr 2001 | EP |
1093772 | Apr 2001 | EP |
A 1138280 | Oct 2001 | EP |
0808140 | Dec 2001 | EP |
1163991 | Dec 2001 | EP |
1212991 | Jun 2002 | EP |
1266636 | Dec 2002 | EP |
1380270 | Jan 2004 | EP |
1415617 | Apr 2004 | EP |
1 611 867 | Jan 2006 | EP |
1611867 | Jan 2006 | EP |
2 158 880 | Mar 2010 | EP |
2158880 | Mar 2010 | EP |
49 042773 | Apr 1974 | JP |
3109404 | May 1991 | JP |
5161665 | Jun 1993 | JP |
6100054 | Apr 1994 | JP |
09117511 | May 1997 | JP |
18-126862 | Jun 2006 | JP |
18-136382 | Jun 2006 | JP |
1768154 | Oct 1992 | RU |
1812980 | Apr 1993 | RU |
2029527 | Feb 1995 | RU |
1217402 | Mar 1986 | SU |
1237201 | Jun 1986 | SU |
1237202 | Jun 1986 | SU |
1273077 | Nov 1986 | SU |
1342511 | Oct 1987 | SU |
1389778 | Apr 1988 | SU |
1457921 | Feb 1989 | SU |
1482714 | May 1989 | SU |
1560134 | Apr 1990 | SU |
1586718 | Aug 1990 | SU |
1650127 | May 1991 | SU |
1732964 | May 1992 | SU |
WO 9100792 | Jan 1991 | WO |
WO 9222604 | Dec 1992 | WO |
WO 9313824 | Jul 1993 | WO |
WO 9319804 | Oct 1993 | WO |
WO 9403127 | Feb 1994 | WO |
WO 9501761 | Jan 1995 | WO |
WO 9503754 | Feb 1995 | WO |
WO 9505132 | Feb 1995 | WO |
WO 9509586 | Apr 1995 | WO |
WO 9614095 | May 1996 | WO |
WO 9614808 | May 1996 | WO |
WO 9703624 | Feb 1997 | WO |
WO 9707751 | Mar 1997 | WO |
WO 9729716 | Aug 1997 | WO |
WO 9748350 | Dec 1997 | WO |
WO 9806355 | Feb 1998 | WO |
WO 9820811 | May 1998 | WO |
WO 9838947 | Sep 1998 | WO |
WO 9841167 | Sep 1998 | WO |
WO 9844870 | Oct 1998 | WO |
WO 9844873 | Oct 1998 | WO |
WO 9900073 | Jan 1999 | WO |
WO 9926559 | Jun 1999 | WO |
WO 9938455 | Aug 1999 | WO |
WO 9943378 | Sep 1999 | WO |
WO 9943379 | Sep 1999 | WO |
WO 0010487 | Mar 2000 | WO |
WO 0013613 | Mar 2000 | WO |
WO 0042947 | Jul 2000 | WO |
WO 0042948 | Jul 2000 | WO |
WO 0044808 | Aug 2000 | WO |
WO 0051522 | Sep 2000 | WO |
WO 0067675 | Nov 2000 | WO |
WO 0071179 | Nov 2000 | WO |
WO 0105331 | Jan 2001 | WO |
WO 0108599 | Feb 2001 | WO |
WO 0115633 | Mar 2001 | WO |
WO 0121108 | Mar 2001 | WO |
WO 0130270 | May 2001 | WO |
WO 0141675 | Jun 2001 | WO |
WO 0156500 | Aug 2001 | WO |
WO 0156504 | Aug 2001 | WO |
WO 0158384 | Aug 2001 | WO |
WO 0158387 | Aug 2001 | WO |
WO 0166037 | Sep 2001 | WO |
WO 0167993 | Sep 2001 | WO |
WO 0174270 | Oct 2001 | WO |
WO 0182836 | Nov 2001 | WO |
WO 0236332 | May 2002 | WO |
WO 0241804 | May 2002 | WO |
WO 02078569 | Oct 2002 | WO |
WO 02083038 | Oct 2002 | WO |
WO 02100454 | Dec 2002 | WO |
WO 03022180 | Mar 2003 | WO |
WO 03053287 | Jul 2003 | WO |
WO 03053288 | Jul 2003 | WO |
WO 03094795 | Nov 2003 | WO |
WO 03094799 | Nov 2003 | WO |
WO 2004002370 | Jan 2004 | WO |
WO 2004002371 | Jan 2004 | WO |
WO 2004017866 | Mar 2004 | WO |
WO 2004078065 | Sep 2004 | WO |
WO 2005037076 | Apr 2005 | WO |
WO 2005086942 | Sep 2005 | WO |
WO 2006107562 | Oct 2006 | WO |
WO 2008115678 | Sep 2008 | WO |
WO 2009042796 | Apr 2009 | WO |
WO 2009086200 | Jul 2009 | WO |
WO 2011100367 | Aug 2011 | WO |
WO 2012068175 | Aug 2012 | WO |
Entry |
---|
US 6,413,270, 7/2002, Thornton et al. (withdrawn). |
Blum et al. “Abdominal aortic aneurysms: preliminary technical and clinical results with transfemoral placement of endovascular self-expanding stent-grafts” Radiology 198(1):25-31 (1996). ;198(1):25-31 (1996). |
Blum et al. “Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms” N Engl J Med 336(1):13-20 (1997). ;336(1):13-20 (1997). |
Campbell et al., “Balloon-Artery Interactions During Stent Placement: A Finite Element Analysis Approach to Pressure, Compliance, and Stent Design as Contributors to Vascular Injury”; 1999; American Heart Association; pp. 378-383. |
Canero et al., “Optimal stent implantation: three-dimensional evaluation of the mutual position of stent and vessel via intracoronary echocardiography,” Computers in Cardiology, 261-264 (Sep. 1999). |
Cooley, Denton A., Surgical Treatment of Aortic Aneurysms (Book), W.B. Saunders Company, West Washington Square, PA (1986). |
Donayre, et al., “Fillable endovascular aneurysm repair”, Endovascular Today, p. 64-66, Jan. 2009. |
Dumoulin C. et al., “Mechanical behavior modeling of balloon expandable stents.” Journal of Biomechanics, vol. 33, No. 11, pp. 1461-1470 (available online: Sep. 8, 2000). |
Elger et al. “The Influence of Shape on the Stresses in Model Abdominal Aortic Aneurysms,” Transactions of the ASME 326:326-32 (1996). |
Ernst “Current therapy for infrarenal aortic aneurysms” N Engl J Med 336(1):58-60 (1997). |
Haimovitch, L. and Patierson, N., “Robust growth is forecast for endovascular repair of AAAs,” The BBI Newsletter, vol. 26, No. 5, pp. 113-144, (May 2003). |
How et al. “Mechanical Properties of Arteries and Arterial Grafts,” Chapter 1 of Cardiovascular Biomaterials Hasting, G.W. (ed.) London; New York: Springer-Verlag, 1992 pp. 1-35. |
Lakshmiraghavan, M. Mechanical Wall Stress in Abdominal Aortic Aneurysm: Towards the Development of a Clinical Tool to Predict Aneurysm Rupture. Submitted to the University of Pittsburgh, vol. 59/09-B of Dissertation Abstracts International p. 4948. 285 pages. (1998). |
Mandai, S. et al. (1992). “Direct Thrombosis of Aneurysms with Cellulose Acetate Polymer. Part I: Results of Thrombosis in Experimental Aneurysms,” J. Neurosurgery 77:497-500. |
Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study”, Radiology, 170/3:1033-1037 (1989); 1033-1037 (1989). |
Moore et al. “Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT phase 1 trial” J Vasc Surg 23(4):543-553 (1996). ;23(4):543-553 (1996). |
Mower et al. “Stress Distributions in Vascular Aneurysms: Factors Affecting Risk of Aneurysm Rupture,” J. Surgical Research 55:151-61 (1993). |
Parodi “Endovascular repair of abdominal aortic aneurysms and other arterial lesions” J Vasc Surg 21(4):549-557 (1995).;21(4):549-557 (1995). |
Parodi et al., “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms,” Ann. Vasc. Surg., 5(6):491-499 (1991). |
Perry, M. D. and Chang, R. T., “Finite Element Analysis of NI-TI Alloy Stent Deployment,” Proceedings of the Second International Conference on SMST, Asilomar Conference Center, Pacific Grove CA. USA (1997). |
Rogers et al., “Balloon-Artery Interactions During Stent Placement: A finite element analysis approach to pressure, compliance and stent design as contributors to vascular injury”, 1999 American Heart Association pp. 378-383. |
Stern et al., “Interactive Definition of Endoluminal Aortic Stent Size and Morphology Based on Virtual Angioscopic Rendering of 3D Magnetic Resonance Angiography (MRA),” Cars. Computer Assisted Radiology and Surgery, Proceedings of the International Symposium on Computer Assisted Radiology and Surgery:176-180 (Jun. 1999). |
The AneuRx® Stent Graft System Treatment for AAA brochure, “An Innovative Modular Approach for the Treatment of Abdominal Aortic Aneurysms (AAA),” Medtronic Ave, Inc. 1999. |
The AneuRx® Stent Graft Treatment for TAA brochure, “An Endoluminal Solution for the Treatment of Descending Thoracic Aortic Aneurysms,” Medtronic, Inc. 1999. |
U.S. Appl. No. 10/168,053, filed Jun. 14, 2002, entitled Inflatable Intraluminal Graft, by C. Murch. |
Uflacker, R. and Robinson, J., “Endovascular treatment of abdominal aortic aneurysms: a review,” Eur. Radial., 11:739-753 (2001). |
Verhagen “Latest AAA Innovations: The Rndurant Stent Graft System”, Veith Symposium Nov. 17, 2007. |
Verhagen, Hence J.M. “Endurant Medtronic Endograft for EVAR: advantages & early experience”, Slides from Veith Symposium Presentation Nov. 22, 2008. |
Volodos, N.L. et al. (1987). “New Balloon Catheter for Dilating Arteries and Installing Prosthesis During Distal Endoprosthetics With Self-Fixing Synthetic Prosthesis,” Thesis of VIII Symposium (Oct. 8-10, 1987), Abstract Only in English, four pages. |
Volodos, N.L. et al. (1986) “Self-Fixing Synthetic Prostheisis for Endoprosthesis of Vessels,” Vestnik Khigurgii pp. 123-124, Abstract Only in English. |
Volodos, N.L. et al. (1989). “Clinical Experience in Use of Self-Fixing Synthetic Prosthesis for Distal and Intraoperative Endoprosthestics of Aora and Iliac Arteries,” Theses of lxth All-Union Symposium (Oct. 2-3, 1989), Abstract only in English, four pages. |
Vos, A.F.W. et al., “Endovascular Grafting of Complex Aortic Aneurysms with a modular Side Branch Stent Graft System in a Porcine Model”, Eur J Vasc Endovasc Surg, May 2004 vol. 27 492-497. |
Web page, “Drug Eluting Stents—Why Use Drug Eluting Stents?;” Polymer Coatings Division; at URL http://www.lombardmedlcal.co.uk/lombard/pcde.why.html; Lombard Medical; printed Feb. 1, 2005. |
Whitcher, “Simulation of in vivo loading conditions of nitinol vascular stent structures”, 1997, Elsevier Science Ltd., pp. 1005-1011. |
Whitcher, F., “A Finite Element Treatment of the In-Vivo Loading Conditions of NITI Ad Vascular Stent and Graft Structures,” Proceedings of the Second International Conference on SMST, Asilomar Conference Center, Pacific Grove. CA, USA (1997). |
Wisselink, W. et al. (2001). “Clipping of Inferior Mesenteric and Lumbar Arteries via Retroperitoneal Laparo-Endoscopic Approach as a Treatment of Persistent Endoleak” Chapter 18 In Endoleaks and Endotension, Veith, F.J. et al. eds. Marcel Dekker, Inc. pp. 211-220. |
Extended European Search Report dated: Dec. 17, 2012 in European Application No. EP 08835032 filed: Oct. 3, 2008. |
Extended European Search Report Mailed Jul. 27, 2010 in European Application No. 10005904.7 filed: Apr. 11, 2002 and published as: EP 2221023 on Aug. 25, 2010. |
Extended European Search Report Mailed Dec. 16, 2009 in European Application No. 09175398.8 filed: Oct. 15, 2004 and published as: EP 2145607 on Jan. 20, 2010. |
Extended European Search Report dated: Apr. 5, 2013 in European Application No. EP 08849544 filed: Nov. 13, 2008. |
International Preliminary Report on Patentability mailed on Apr. 15, 2010 for International Application No. PCT/US2008/078846 filed on Oct. 3, 2008 and published as WO/2009/046372 on Apr. 9, 2009. |
International Search Report and Written Opinion mailed on Jul. 30, 2009 for International Application No. PCT/US2008/078846 filed on Oct. 3, 2008 and published as WO/2009/046372 on Apr. 9, 2009. |
International Preliminary Report on Patentability mailed on Apr. 8, 2010 for International Application No. PCT/US2008/077714 filed on Sep. 25, 2008 and published as WO/2009/042789 on Apr. 2, 2009. |
International Search Report and Written Opinion mailed on: May 1, 2009 for International Application No. PCT/US2008/077714 filed on Sep. 25, 2008 and published as WO/2009/042789 on Apr. 2, 2009. |
International Preliminary Report on Patentability mailed on May 27, 2010 for International Application No. PCT/US2008/083451 filed on Nov. 13, 2008 and published as WO/2009/064923 on May 22, 2009. |
International Search Report and Written Opinion mailed on Jun. 30, 2009 for International Application No. PCT/US2008/083451 filed on Nov. 13, 2008 and published as WO/2009/064923 on May 22, 2009. |
International Preliminary Report on Patentability mailed on Apr. 8, 2010 for International Application No. PCT/US2008/077727 filed on Sep. 25, 2008 and published as WO2009/042796 on Apr. 2, 2009. |
International Search Report and Written Opinion mailed on Mar. 26, 2009 for International Application No. PCT/US2008/077727 filed on Sep. 25, 2008 and published as WO/2009/042796 on Apr. 2, 2009. |
International Preliminary Report on Patentability mailed on Jul. 1, 2010 for International Application No. PCT/US2008/087831 filed on Dec. 19, 2008 and published as WO/2009/086200 on Jul. 9, 2009. |
International Search Report and Written Opinion mailed on May 28, 2009 for International Application No. PCT/US2008/087831 filed on Dec. 19, 2008 and published as WO/2009/086200 on Jul. 9, 2009. |
International Search Report and Written Opinion mailed on Oct. 31, 2011 for International Application No. PCT/US2011/024248 filed on Feb. 9, 2011 and published as WO/2011/100367 on Aug. 28, 2011. |
International Search Report and Written Opinion mailed on Jul. 18, 2013 for International Application No. PCT/US2013/034654 filed on Mar. 29, 2013. |
International Search Report and Written Opinion mailed on Jul. 18, 2013 for International Application No. PCT/US2013/034787 filed on Apr. 1, 2013. |
Invitation to Pay Additional Fees and Partial Search Report dated: Apr. 25, 2013 for International Application No. PCT/US2011/060873 filed on Nov. 15, 2011 and published as WO/2012/068175 on Aug. 2, 2012. |
International Search Report and Written Opinion mailed on Jun. 12, 2012 for International Application No. PCT/US2011/060873 filed on Nov. 15, 2011 and published as WO/2012/068175 on Aug. 2, 2012. |
Office Action Response mailed: Jul. 18, 2011 in U.S. Appl. No. 12/245,620, filed Oct. 3, 2008 and published as: US2009/0099649 on Apr. 16, 2009. |
Office Action mailed: Jan. 19, 2011 in U.S. Appl. No. 12/245,620, filed Oct. 3, 2008 and published as: US2009/0099649 on Apr. 16, 2009. |
Office Action Response mailed: Nov. 12, 2010 in U.S. Appl. No. 12/245,620, filed Oct. 3, 2008 and published as: US2009/0099649 on Apr. 16, 2009. |
Office Action mailed: May 14, 2010 in U.S. Appl. No. 12/245,620, filed Oct. 3, 2008 and published as: US2009/0099649 on Apr. 16, 2009. |
Office Action Response mailed Oct. 24, 2012 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Apr. 27, 2012 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Sep. 14, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action Response mailed Jul. 15, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Mar. 15, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action Response mailed Jan. 26, 2011 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Aug. 26, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action Response mailed Jun. 14, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Jan. 14, 2010 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action mailed: Jun. 7, 2012 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed: Apr. 11, 2012 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action Response mailed: Mar. 20, 2012 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed: Dec. 7, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action Response mailed: Oct. 21, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed: Apr. 26, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action Response mailed: Apr. 5, 2011 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed: Oct. 6, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action Response mailed: Sep. 1, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed: Apr. 1, 2010 in U.S. Appl. No. 11/861,756, filed Sep. 26, 2007 and published as: US2009/0082842 on Mar. 26, 2009. |
Office Action mailed on Jan. 30, 2013 in U.S. Appl. No. 12/747,499, filed on Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
Office Action Response mailed on Dec. 11, 2012 in U.S. Appl. No. 12/747,499, filed on Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
Office Action mailed on Jun. 18, 2012 in U.S. Appl. No. 12/747,499, filed on Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
Office Action Response mailed on May 17, 2012 in U.S. Appl. No. 12/747,499, filed on Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
Office Action mailed on Nov. 28, 2011 in U.S. Appl. No. 12/747,499, filed on Sep. 7, 2010 and published as: US2010/0331958 on: Dec. 30, 2010. |
Office Action mailed: Mar. 13, 2012 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action Response mailed: Dec. 15, 2011 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action mailed: Jun. 21, 2011 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action Response mailed: May 23, 2011 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action mailed: Nov. 23, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action Response mailed on Oct. 12, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action mailed: Apr. 14, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action Response mailed: Jan. 4, 2010 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
Office Action mailed: Oct. 1, 2009 in U.S. Appl. No. 11/861,731, filed Sep. 26, 2007 and published as: US2009/0082847 on Mar. 26, 2009. |
International Search Report and Written Opinion mailed on Jul. 18, 2013 for International Application No. PCT/US2013/034654, filed on Mar. 29, 2013 and published as WO 2013/151896 on Oct. 10, 2013. |
International Search Report and Written Opinion mailed on Jul. 18, 2013 for International Application No. PCT/US2013/034787, filed on Apr. 1, 2013 and published as WO 2013/151924 on Oct. 10, 2013. |
Office Action mailed on Sep. 18, 2013 in U.S. Appl. No. 11/861,828, filed on Sep. 26, 2007 and published as 2009-0082846 on Mar. 26, 2009. |
Office Action Response dated: Jun. 30, 2014 in U.S. Appl. No. 13/297,219, filed Nov. 15, 2011 and published as: US2012/0191174 on: Jul. 26, 2012. |
Office Action mailed: Jun. 19, 2014 in U.S. Appl. No. 12/245,620, filed Oct. 3, 2008 and published as: US2009/0099649 on Apr. 16, 2009. |
Office Action mailed May 22, 2014 in U.S. Appl. No. 11/861,739, filed Sep. 26, 2007 and published as: US2009/0082841 on Mar. 26, 2009. |
Office Action dated: Oct. 1, 2014 in U.S. Appl. No. 13/297,219, filed Nov. 15, 2011 and published as: US2012/0191174 on: Jul. 26, 2012. |
Office Action dated: Mar. 28, 2014 in U.S. Appl. No. 13/297,219, filed Nov. 15, 2011 and published as: US2012/0191174 on: Jul. 26, 2012. |
Number | Date | Country | |
---|---|---|---|
20130268044 A1 | Oct 2013 | US |
Number | Date | Country | |
---|---|---|---|
61620362 | Apr 2012 | US |